var  groupall = {
    "feature_count": 2049,
    "type": [
        "FeatureCollection"
    ],
    "features": [
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183622",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 201, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2015-06-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease",
                "aff": "Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02580617",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 208, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04497805",
                "enrolled": 64,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 219, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2020-01-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394886",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 238, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2014-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03754465",
                "enrolled": 56,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 240, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2019-01-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03183648",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 248, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-06-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.",
                "aff": "Korea University Kuro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03370874",
                "enrolled": 164,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 203, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2018-07-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Korea University Guro Hospital, Guro-gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 203, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Eulji General Hospital, Nowon-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 203, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Severance Hospital, Seodaemun-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 203, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers",
                "aff": "Asan medical center, Songpa-Gu, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619877",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 203, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02394873",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 211, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2015-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",
                "aff": "Section of Colon and Rectal Surger, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02384499",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 233, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-03-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects",
                "aff": "Hallym university Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02619851",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 210, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03449082",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 243, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-05-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Mesenchymal Stem Cells",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01856140",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 207, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-05-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 245, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 245, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Samsung medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 245, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02131077",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 245, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.",
                "aff": "University of Texas Rio Grande Valley School of Medicine, Harlingen, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03265808",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 226, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 232, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-03-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01087996",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 232, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-03-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery",
                "aff": "ISCI/University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02065245",
                "enrolled": 65,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 247, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2014-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02886884",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 204, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)",
                "aff": "University of Miami School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01392625",
                "enrolled": 37,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 232, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2011-05-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)",
                "aff": "ISCI / University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02013674",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 218, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 202, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 202, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 202, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy",
                "aff": "Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04476901",
                "enrolled": 136,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 202, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.",
                "aff": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01956903",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 243, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-09-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 242, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-05-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
                "aff": "Instituto de Biologia y Genetica Molecular, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01860417",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 242, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-05-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Centro Medico Teknon, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 246, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells",
                "aff": "Hospital Clinico Universitario, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01586312",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 246, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",
                "aff": "University Hospital La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01678534",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 245, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital de Jerez de la Frontera., Jerez de la Frontera, C\u00e1diz., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 246, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada., Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 246, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Universitario Virgen del Roc\u00edo de Sevilla, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 246, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",
                "aff": "Hospital Cl\u00ednico de Valencia, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01222039",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 246, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Valle de Hebr\u00f3n, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 228, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario Fundaci\u00f3n Jim\u00e9nez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 228, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease",
                "aff": "Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05521672",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 228, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke",
                "aff": "Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03384433",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 231, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-04-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04184258",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 202, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19",
                "aff": "Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04615429",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 234, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-08-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 214, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2017-08-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03326505",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 214, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2017-08-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV)",
                "aff": "Hospital Universitario Rio Hortega, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04361942",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 208, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Centre for Liver Research & Diagnostics, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78,
                    15
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Mediciti Hospital, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78,
                    15
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Manipal Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "KMC Hospital, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Institute of liver disease, HPB surgery and transplant Global Hospitals, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72,
                    19
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Bombay Hospital & Medical Research Center, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72,
                    19
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Ruby Hall clinic, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "Sahyadri Speciality Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SMS Medical college and Hospital, Jaipur, Rajasthan, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    75,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis",
                "aff": "SGPGI Lucknow, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01591200",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Critical Limb Ischemia",
                "aff": "M.S.Ramaiah Memorial Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883870",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 235, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Critical Limb Ischemia",
                "aff": "Bhagawan Mahaveer Jain Heart Centre, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883870",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 235, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Critical Limb Ischemia",
                "aff": "Amrita Institute of Medical Sciences, Kochi, Kerala, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883870",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 235, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    76,
                    9
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Critical Limb Ischemia",
                "aff": "Sri Ganga Ram Hospital, New Delhi, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883870",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 235, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "Care Hospital, Hyderabad, Andhra Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 224, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78,
                    15
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "SAL Hospital and Medical Institute, Ahmedabad, Gujarat, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 224, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "MS Ramaiah Memorial Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 224, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI",
                "aff": "Bhagawan Mahaveer Jain Heart Centre, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT00883727",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 224, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula",
                "aff": "Instituto Investigaci\u00f3n Sanitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03726255",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 244, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy",
                "aff": "IOBA - Applied Ophthalmobiology Institute, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03173638",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 227, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2018-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Wharton\u00b4s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes",
                "aff": "Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge, Huddinge, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03973827",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 234, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-05-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Hospital Clinic, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Hospital Cl\u00ednico Universitario San Carlos, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Hospital Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Hospital Gregorio Mara\u00f1\u00f3n, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Hospital Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Hospital Universitario Virgen de la Victoria, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Cl\u00ednica Universidad de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Complejo Asistencial Universitario de Salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.",
                "aff": "Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05086939",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 231, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT02336646",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 221, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD",
                "aff": "Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Punjab, Pakistan",
                "url": "https://ClinicalTrials.gov/show/NCT02824653",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 208, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-07-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04382547",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 241, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-05-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03522545",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 207, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells",
                "aff": "Saint-Louis Hospital, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02213705",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 219, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of California San Francisco Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 246, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Stanford University Medical Center, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 246, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 246, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01775774",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 246, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "Mercy Gilbert and Chandler Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 216, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California Irvine Department of Neurology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 216, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke",
                "aff": "University of California San Diego Division of Neurological Surgery, San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01297413",
                "enrolled": 38,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 216, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04776239",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-03-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02140528",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 220, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis",
                "aff": "University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02866721",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 228, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2016-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells",
                "aff": "University of Illinois, Department of Ophthalmology and Visual Sciences, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04626583",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 227, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-03-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Clinica Universitaria de Navarra, Av Pio XII ,36, Pamplona, Navarra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 220, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Universitario Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 220, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 220, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 220, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Hospital clinico universitario de salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 220, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial With MSC for Graft Versus Host Disease Treatment",
                "aff": "Virgen del Rocio University Hospital, av. Manuel Siurot s/n, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02687646",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 220, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy",
                "aff": "Cipto Mangunkusumo General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04876326",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-09-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 233, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 233, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 233, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Minnesota Medical Center, Saint Paul, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 233, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 233, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02097641",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 233, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10757 - Cardiology, P.C., Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10786 - Cardiovascular Associates of Mesa, Mesa, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10756 - Mayo Clinic, Phoenix, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -112,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13023 - University of Arizona Medical Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10754 - University of California, San Diego, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10759 - Scripps Clinic, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13265 - University of California, Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10775 - Cedars-Sinai Medical Care Foundation, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10778 - Orange County Cardiology, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13031 - St. John's Regional Medical Center, Oxnard, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -119,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13275 - Stanford University Hospital, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13267 - Bethesda Heart Hospital, Boynton Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10780 - Morton Plant Hospital, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10760 - Shands Hospital, University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13273 - University of Florida Health, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10768 - University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13280, Orlando, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13264 - Florida Hospital Pepin Heart Institute, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13027 - Emory University School of Medicine, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10765 - Georgia Regents University, Augusta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10772 - University Cardiologist, Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13030 - University of Iowa, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10783 - Gill Heart Institute, University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13022 - University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13266, New Orleans, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10782, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10766 - Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10762 - Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10761 - Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13281, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13263 - RWJ Barnabas Heart Center, Newark, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10776 - Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13026 - Sanger Heart and Vascular Institute, Carolinas Healthcare System, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10781 - Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10758 - The Christ Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10770 - University of Cincinnati, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10773, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13278 - OhioHealth Research Institute, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10785 - Lehigh Valley Hospital, Allentown, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13261 - University of Pennsylvania, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10767 - Temple University Hospital, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13277, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10774 - University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13024 - Austin Heart, PLLC, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10755 - Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13268 - Houston Methodist Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10763 - University Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10764 - University of Wisconsin, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10769 - Aurora Healthcare, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 13279, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 10789 - Aspirus Research Institute, Wausau, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11027, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11024 - Victoria Heart Institute Foundation, Victoria, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
                "aff": "Mesoblast Investigational Site 11025 - St. Michael's Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02032004",
                "enrolled": 566,
                "radius": 33,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9967,
                "paneLabel": "pane9967",
                "start": "2014-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients",
                "aff": "Leiden University Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT02387151",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 229, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-03-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04388761",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 202, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease",
                "aff": "Children's National Medical Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02150551",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 229, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2015-05-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03929120",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 223, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-10-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction",
                "aff": "National Research Medical Center, Astana, Kazakhstan",
                "url": "https://ClinicalTrials.gov/show/NCT02672267",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 240, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-02-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    71,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05286255",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 228, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-05-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis",
                "aff": "Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT02641860",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 246, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Immunotherapy for Septic Shock: A Phase I Trial",
                "aff": "The Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02421484",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 229, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-04-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "China-Japan Friendship Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Huashan Hospital Affiliated to Fudan University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai General Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai Sixth People's Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis",
                "aff": "Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04208646",
                "enrolled": 108,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital General de Alicante, Alicante, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Gregorio Mara\u00f1on, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "La Paz University Hospital, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Clinica Universidad de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario de Salamanca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Victoria Eugenia Cruz Roja Espa\u00f1ola, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital Universitario La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Hospital de Valladolid, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04466007",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 212, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth",
                "aff": "Department of Otolaryngology, Rigshospitalet, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03874572",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 212, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)",
                "aff": "Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02298023",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 221, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome",
                "aff": "Uppsala University Hospital, Uppsala, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT04447833",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 221, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2020-06-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT01649687",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 217, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2012-07-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, C\u00e1diz, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 224, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 224, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 224, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Universitario Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 224, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Unversitario Virgen del Roc\u00edo, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 224, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",
                "aff": "Hospital Nuestra Se\u00f1ora de Valme, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04366323",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 224, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Pinnacle Research Group, Anniston, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthrocare Arthritis Care and Research PC, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Triwest Research Associates, El Cajon, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Inland Rheumatology Clinical Trials Incorporated, Upland, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Ocala Rheumatology Research Center, Ocala, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Center, Palm Harbor, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Sarasota Arthritis Research Center, Sarasota, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "McIlwain Medical Group, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "JHU Arthritis Center Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Arthritis Treatment Center, Frederick, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Reliant Medical Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Office of Ramesh C. Gupta, MD, Fair Lawn, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "DJL Clinical Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Health Research of Oklahoma, Oklahoma City, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "West Tennessee Research Institute, Jackson, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Accurate Clinical Research, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Texas Arthritis Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Southern Clinical Research Pty Ltd, Hobart, Tasmania, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    147,
                    -42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF\u03b1 Inhibitor",
                "aff": "Emeritus Research, Malvern, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01851070",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2013-05-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord",
                "aff": "Saint-Louis Hospital, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT03562065",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 237, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-08-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis",
                "aff": "Department of Gastroenterology; Gulhane Military Medical Academy, Ankara, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT01378182",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 247, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-06-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    32,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B",
                "aff": "Cipto Mangunkusumo hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04357600",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 216, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-05-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis",
                "aff": "University of Miami Hospitals & Clinics, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02625246",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 207, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2016-02-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus",
                "aff": "Universidad de Chile Clinical Hospital, Santiago, Independencia, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT03905824",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 226, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2019-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 232, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04869761",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 232, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, M. S. Ramaiah Memorial Hospital, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 243, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Orthopedics, Kasturba Medical College, Manipal, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 243, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 243, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    72,
                    19
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Jehangir Hospital, Pune, Maharashtra, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 243, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells in Osteoarthritis",
                "aff": "Department of Immunology Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India",
                "url": "https://ClinicalTrials.gov/show/NCT01453738",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 243, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease",
                "aff": "University of Malaya Medical Centre, Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05039411",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2022-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    3
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02611167",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 209, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis",
                "aff": "Hanyang university hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03174587",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 205, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-05-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium",
                "aff": "Sholahuddin Rhatomy, Sleman, Yogyakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04889963",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 205, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05532943",
                "enrolled": 41,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 209, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-11-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05501418",
                "enrolled": 75,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 235, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2022-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sj\u00f6gren's Syndrome",
                "aff": "Rigshospitalet, Copenhagen, DK, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT04615455",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 216, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation",
                "aff": "Indiana University, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02685098",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 200, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-02-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04791878",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 205, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 230, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05362786",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 230, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04835883",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 223, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-08-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, Delhi, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Division of Peripheral Vascular and Endovascular Sciences, Medanta - The Medicity, Gurgaon, Haryana, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Peripheral Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences & Research, Bangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    77,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Surgery, KMC, Mangalore, Mangalore, Karnataka, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Madras Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Sri Ramchandra Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, Stanley Medical College, Chennai, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    80,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Department of Vascular Surgery, AMRI Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease",
                "aff": "Nightingale Hospital, Kolkata, West Bengal, India",
                "url": "https://ClinicalTrials.gov/show/NCT01484574",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    88,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "MedStar Washington Hospital Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 241, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Emory University Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 241, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Northwestern University Centers for Heart Failure Therapy, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 241, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Stony Brook Heart Institute, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 241, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure",
                "aff": "Hospital of the University of Pennsylvania, Heart Failure and Transplant Program, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02467387",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 241, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia",
                "aff": "The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04255147",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 206, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04056819",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 217, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-05-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Pantai Cheras Medical Centre, Kuala Lumpur, Federal territory, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 216, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    3
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Serdang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 216, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    2
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "KPJ Ampang Puteri Specialist Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 216, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    2
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for Osteoarthritis",
                "aff": "Selayang Hospital, Kuala Lumpur, Selangor, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT01448434",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 216, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2011-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    2
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04519697",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 207, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04519671",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 207, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)",
                "aff": "Asthma and Allergy Consultants, Wichita, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02235844",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 226, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2014-08-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Moewardi General Hospital, Surakarta, Central Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 212, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Hasan Sadikin, Bandung, West Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 212, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    107,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients",
                "aff": "Dr. Sardjito General Hospital, Yogyakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05132972",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 212, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04519684",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 204, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Perinatal Arterial Stroke Treated With Stromal Cells Intranasally",
                "aff": "Wilhelmina Childrens Hostpital/University Medical Center Utrecht, Utrecht, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT03356821",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 205, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-02-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Wharton\u00b4s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes",
                "aff": "Karolinska Trial Alliance, Fas 1 enheten, Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03406585",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease",
                "aff": "Rigshospitalet, Copenhagen, DK, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03878628",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 217, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-09-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells",
                "aff": "University Hospital R\u00edo Hortega, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03673748",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 226, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04939077",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 222, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD).",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04995081",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 210, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-07-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Interferon \u03b3-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease",
                "aff": "Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04328714",
                "enrolled": 45,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 249, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Interferon \u03b3-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04328714",
                "enrolled": 45,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 249, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Interferon \u03b3-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease",
                "aff": "Winship Cancer Institute of Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04328714",
                "enrolled": 45,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 249, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro",
                "aff": "University Clinical Hospital of Salamanca, Salamanca, Salamanca/Castilla Le\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02104440",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 201, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-04-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB",
                "aff": "GangnamSeverance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04520022",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 200, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2016-09-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Stem Cells and Spinal Fusion",
                "aff": "Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01552707",
                "enrolled": 69,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 241, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2012-07-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Stem Cells and Spinal Fusion",
                "aff": "Parc de Salut Mar, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01552707",
                "enrolled": 69,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 241, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2012-07-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Stem Cells and Spinal Fusion",
                "aff": "Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01552707",
                "enrolled": 69,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 241, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2012-07-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Stem Cells and Spinal Fusion",
                "aff": "Institut Universitari Dexeus (ICATME), Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01552707",
                "enrolled": 69,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 241, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2012-07-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Stem Cells and Spinal Fusion",
                "aff": "Hospital Vall d'Hebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01552707",
                "enrolled": 69,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 241, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2012-07-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell and Conditioned Medium for Cerebral Palsy",
                "aff": "Indonesian National Brain Center, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04314687",
                "enrolled": 78,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 233, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2021-09-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury",
                "aff": "Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM-UKM), Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT05016011",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 235, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    3
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response",
                "aff": "Virgen del Roc\u00edo University Hospital, Seville, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02290041",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 213, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-02-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic MSC Treatment for Pulmonary Emphysema",
                "aff": "Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT04918706",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 229, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03265613",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 222, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147675",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 206, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-11-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152290",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 247, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158127",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 217, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147701",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 215, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147766",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 239, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158933",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 249, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Stroke",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158101",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 240, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147688",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 242, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-11-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018858",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 229, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Parkinson's Disease",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152394",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 209, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003960",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 220, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018819",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 236, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003908",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 232, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003388",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 215, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003934",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 224, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152381",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 235, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018832",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 224, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018845",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 246, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003947",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 227, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05016804",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05018767",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 242, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05016817",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 201, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05003921",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 209, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05158114",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 249, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05042206",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04506073",
                "enrolled": 45,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 201, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients",
                "aff": "Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04336254",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 213, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease",
                "aff": "John Wayne Cancer Institute @ Providence St. John's Health Center, Santa Monica, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02833792",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 226, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia",
                "aff": "IMAC Regeneration Center, Paducah, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04385056",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 227, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia",
                "aff": "Ozzie Smith IMAC Regeneration Center, Chesterfield, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04385056",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 227, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia",
                "aff": "David Price IMAC Regeneration Center, Brentwood, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04385056",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 227, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients",
                "aff": "Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04535856",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 213, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-10-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119,
                    -5
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "Teradan Clinical Trials LLC, Brandon, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "Sarasota Memorial Health Care System (SMH), Sarasota, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "St Luke's Research, Boise, Idaho, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "St. Luke's Boise, Boise, Idaho, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "Ascension St. John, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress",
                "aff": "PRX Research/Dallas Regional Medical Center, Mesquite, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04905836",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease",
                "aff": "Federal Research Clinical Center FMBA of Russia, Moscow, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT02594839",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 248, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-10-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    37,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy",
                "aff": "AHEPA University Hospital, Thessaloniki, Greece",
                "url": "https://ClinicalTrials.gov/show/NCT01753440",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 206, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-11-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    22,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue",
                "aff": "Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03798353",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 206, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones",
                "aff": "Hospital ASEPEYO Sant Cugat, Sant Cugat, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02230514",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 247, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-10-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19",
                "aff": "Providence Medical Foundation, Fullerton, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04780685",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 248, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19",
                "aff": "Providence Saint John's Health Center - Saint John's Cancer Institute, Santa Monica, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04780685",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 248, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells",
                "aff": "Medical University of Warsaw, Department of Diabetology and Internal Diseases, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03865394",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 246, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome",
                "aff": "IOBA, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01562002",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 224, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Mercy Gilbert Medical Center, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 241, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "University of California, San Diego, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 241, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Minneapolis Heart Institute 920 East 28th St, Suite 300, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 241, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "UPMC, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 241, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Texas Heart Institue, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 241, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure",
                "aff": "Swedish Heart and Vascular Institute, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00721045",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 241, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of California Davis Medical Center, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818854",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-10-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                "aff": "Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818854",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-10-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                "aff": "University of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818854",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-10-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818854",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-10-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818854",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-10-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                "aff": "Memorial Hermann Hospital - Texas Medical Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818854",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-10-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome",
                "aff": "Harborview Medical Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818854",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-10-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03589287",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 216, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-05-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04348435",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 207, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-05-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of UCB and MSCs in Children With CP: ACCeNT-CP",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03473301",
                "enrolled": 91,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 212, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-04-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03684122",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 233, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04869397",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 215, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-06-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation",
                "aff": "St. Jude Children's Research Hospital, Memphis, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00186914",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 237, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "1999-08-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis",
                "aff": "Scott Medical Health Center, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03337243",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 219, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2017-10-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Injection in Cancer Survivors",
                "aff": "Stanford University School of Medicine, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02509156",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 231, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Injection in Cancer Survivors",
                "aff": "University of Florida-Department of Medicine, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02509156",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 231, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Injection in Cancer Survivors",
                "aff": "University of Miami-Interdiciplinary Stem Cell Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02509156",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 231, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Injection in Cancer Survivors",
                "aff": "Indiana Center for Vascular Biology and Medicine, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02509156",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 231, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Injection in Cancer Survivors",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02509156",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 231, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Injection in Cancer Survivors",
                "aff": "Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02509156",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 231, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Injection in Cancer Survivors",
                "aff": "Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02509156",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 231, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-07-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn",
                "aff": "Saint Louis Hospital, APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT03967275",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 209, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2020-08-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04661644",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 239, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head",
                "aff": "Hospital Universitari Vall d'Hebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01605383",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 208, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-05-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05126563",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2022-01-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis",
                "aff": "Unidad de Terapia Celular del Instituto de Investigaciones Cient\u00edficas, San Antonio de los Altos, Miranda, Venezuela",
                "url": "https://ClinicalTrials.gov/show/NCT04545307",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 201, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -66,
                    10
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome",
                "aff": "Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04289194",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 249, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome",
                "aff": "Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04289194",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 249, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT04785027",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 205, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-03-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "University of Minnesota, Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 245, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-01-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "EB-Haus Austria; Salzburger Landeskliniken (SALK); Paracelsus Medizinische Privatuniversit\u00e4t Salzburg (PMU), Salzburg, Austria",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 245, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-01-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "H\u00f4pital Saint-Louis; D\u00e9partement de dermatologie, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 245, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-01-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 245, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-01-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "King's College London; St John's Institute of Dermatology;, London, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 245, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-01-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa",
                "aff": "Great Ormond Street Hospital; Dermatology Department, London, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03529877",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 245, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-01-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD",
                "aff": "University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05333029",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 203, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-04-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02192749",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 207, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    8
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines",
                "aff": "M D Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02408432",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 249, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2016-01-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Instituto Oftalmol\u00f3gico Fern\u00e1ndez - Vega, Oviedo, Asturias, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Hospital General La Mancha Centro, Alc\u00e1zar De San Juan, Ciudad Real, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Hospital La Arruzafa, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Hospital General Universitario Gregorio Mara\u00f1on, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Hospital Universitario Fundaci\u00f3n Jim\u00e9nez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Hospital Universitario La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.",
                "aff": "Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05520086",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell in Acute Myocardial Infarction",
                "aff": "PT Prodia StemCell Indonesia, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04340609",
                "enrolled": 4,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 224, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-03-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease",
                "aff": "Leiden University Medical Center (LUMC), Leiden, Zuid Holland, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01144962",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 242, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-06-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05152368",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 223, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis",
                "aff": "Medical Surgical Associates Center, St. John's, Antigua and Barbuda",
                "url": "https://ClinicalTrials.gov/show/NCT05147779",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 228, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-11-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -61,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy",
                "aff": "Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04758533",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 203, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic BM-MSCs in Patients With Lumbar Facet Arthropathy",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04410731",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 231, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-04-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke",
                "aff": "Hospital Universitario La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04280003",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 226, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-01-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP)",
                "aff": "Children's National Health System, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04236479",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 236, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-07-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Soffer Health Institute, Aventura, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Panax Clinical Research, Miami Lakes, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty",
                "aff": "Advanced Research for Health Improvement, LLC, Naples, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03169231",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-07-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Augsburg, Klinik f\u00fcr Dermatologie und Allergologie, Campus S\u00fcd, Augsburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Fachklinik Bad Bentheim, Dermatologische Ambulanz, Bad Bentheim, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Franziskus-Krankenhaus Berlin, Klinik f\u00fcr Innere Medizin, Angiologie und Diabetologie, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Klinikum Berlin-Buch, Klinik f\u00fcr Plastische und \u00c4sthetische Chirurgie, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Klinikum Emil von Behring, Klinik f\u00fcr Plastische und \u00c4sthetische Chirurgie, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Hautarztpraxis Dr. Niesmann & Dr. Othlinghaus, Hautzentrum im Jahrhunderthaus, Bochum, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Katholisches Klinikum Bochum gGmbH, Venenzentrum der Kliniken f\u00fcr Dermatologie und Gef\u00e4\u00dfchirurgie der Ruhr-Universit\u00e4t Bochum, Bochum, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Haut\u00e4rzte Braunschweig am Altstadtmarkt, Haut\u00e4rztliche Gemeinschaftspraxis, Braunschweig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinikum Bremerhaven Reinkenheide gGmbH, Klinik f\u00fcr Dermatologie, Allergologie und Phlebologie, Wundzentrum, Bremerhaven, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinische Forschung Dresden GmbH, Dresden, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum \"Carl Gustav Carus\" der Technischen Universit\u00e4t Dresden, Medizinische Klinik und Poliklinik III Angiologie und Gef\u00e4\u00dfzentrum, Dresden, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum D\u00fcsseldorf, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf, Klinik f\u00fcr Dermatologie, D\u00fcsseldorf, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Erlangen, Hautklinik - Wundzentrum Dermatologie, Erlangen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Essen, Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Essen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Freiburg, Klinik f\u00fcr Dermatologie und Venerologie, Freiburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Marienhospital Gelsenkirchen GmbH, Klinik f\u00fcr Chirurgie (Allgemein-, Viszeral- und Endokrine Chirurgie, Thorax-, Gef\u00e4\u00df- und Endovaskul\u00e4re Chirurgie und Kinderchirurgie), Gelsenkirchen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "SRH Wald-Klinikum Gera GmbH, Zentrum f\u00fcr Klinische Studien, Gera, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Praxis Dr. med. Abdou Zarzour, Halle, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Hamburg- Eppendorf, Institut f\u00fcr Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP), Hamburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "MVZ Prof. Dr. Ockenfels, Haut und Allergie-Praxisklinik GmbH, Hanau, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "SRH Klinikum Karlsbad- Langensteinbach GmbH, Interdisziplin\u00e4res Gef\u00e4\u00dfzentrum Innere Medizin, Karlsbad, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Medizinisches Versorgungszentrum DermaKiel GmbH, Kiel, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Klinikum Krefeld, Klinik f\u00fcr Dermatologie und Venerologie, Krefeld, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Hautarztpraxis Langenau, Studienzentrum, Langenau, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum Leipzig A\u00f6R, Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Leipzig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Studienambulanz Dr. Schubert Leipzig, Leipzig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Diabetologikum Ludwigshafen, die Praxis am Ludwigsplatz, Ludwigshafen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Beldio Research GmbH, Memmingen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinikum der Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, Klinik und Poliklinik f\u00fcr Dermatologie und Allergologie, M\u00fcnchen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Dermazentrum M\u00fcnchen, Standort Neuhausen, Studienzentrum, M\u00fcnchen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum M\u00fcnster, Klinik f\u00fcr Hautkrankheiten, Allgemeine Dermatologie und Venerologie, M\u00fcnster, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Klinikum N\u00fcrnberg Nord, Klinik f\u00fcr Dermatologie, N\u00fcrnberg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Hautarztpraxis Prof. Dr. med. Khusru Asadullah, Potsdam, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Caritas-Krankenhaus St. Josef, Klinik f\u00fcr Plastische und \u00c4sthetische, Hand- und Wiederherstellungschirurgie, Regensburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsmedizin Rostock, Klinik und Poliklinik f\u00fcr Dermatologie und Venerologie, Rostock, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Kliniken Schwerin, Plastische, Rekonstruktive und \u00c4sthetische Chirurgie, Schwerin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Haut\u00e4rztliche Gemeinschaftspraxis Dr. Leitz und Kollegen, Stuttgart, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum T\u00fcbingen, Universit\u00e4ts-Hautklinik T\u00fcbingen, T\u00fcbingen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Helios Universit\u00e4tsklinikum Wuppertal, Zentrums f\u00fcr Dermatologie, Allergologie und Dermatochirurgie, Wuppertal, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)",
                "aff": "Universit\u00e4tsklinikum W\u00fcrzburg, Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, W\u00fcrzburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04971161",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Amniotic Membrane and Mesenchymal Stem Cells Composite",
                "aff": "Cell and Tissue Bank - Regenerative Medicine, Dr. Soetomo General Academic Hospital/ Faculty of Medicine Universitas Airlangga, Surabaya, East Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04654286",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 200, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    112,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease",
                "aff": "CHU Sart Tilman, Liege, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00504803",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 236, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2006-07-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03171194",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 224, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03171194",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 224, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers",
                "aff": "Academic Medical Center, Amsterdam, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT02328612",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 216, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-11-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy to Improve Burn Wound Healing",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02104713",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 214, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2014-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "NEPHSTROM for Diabetic Kidney Disease",
                "aff": "National University of ireland - Galway University Hospital -Regenerative Medicine Institute, Galway, Ireland",
                "url": "https://ClinicalTrials.gov/show/NCT02585622",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 240, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -9,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "NEPHSTROM for Diabetic Kidney Disease",
                "aff": "ASST - Papa Giovanni XXIII - U.O. Nefrologia e Dialisi/ Mario Negri Institute for Pharmacological Research - Clinical Research Center for Rare Diseases Aldo e Cele Dacc\u00f2, Bergamo, BG, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02585622",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 240, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "NEPHSTROM for Diabetic Kidney Disease",
                "aff": "Belfast Health and Social Care Trust - Belfast City Hospital, Belfast, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02585622",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 240, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "NEPHSTROM for Diabetic Kidney Disease",
                "aff": "University Hospital Birmingham NHS Foundation Trust - Queen Elizabeth Medical Centre, Birmingham, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02585622",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 240, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia",
                "aff": "Digestive Disease Research Center, Shariati Hospital, North Kargar Ave., Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00515307",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 221, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2007-06-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "Cedars-Sinai Medical Center, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "University of California - San Diego, San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "Northwestern University, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "The Feinstein Institute for Medical Research, Manhasset, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "University of Rochester Medical Center, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02633163",
                "enrolled": 81,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04548583",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 220, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease",
                "aff": "Vinmec International Hospital Times City, H\u00e0 N\u1ed9i, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT04433104",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 228, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04543994",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 229, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Research of South Florida, Coral Gables, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Clinical Physiology Associates, Fort Myers, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Vista Health Research, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty",
                "aff": "Optimal Research LLC, Rockville, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02982915",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-11-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy",
                "aff": "Universidad de los Andes, Santiago de Chile, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT01739777",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 207, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-11-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04392206",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 234, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-05-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy",
                "aff": "Monash Universtiy, Clayton, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01843387",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 248, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-04-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy",
                "aff": "Melbourne Renal Research Group, Melbourne, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01843387",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 248, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-04-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation",
                "aff": "2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT04714801",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 235, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Alzheimer's Disease Stem Cells Multiple Infusions",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04040348",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 229, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-09-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Comparative Effectiveness of Arthroscopy and Non-Arthroscopy Using Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium for Osteoartrithis",
                "aff": "Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04314661",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 202, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia",
                "aff": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04276987",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 231, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-02-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus",
                "aff": "Clementino Fraga Filho University Hospital of Rio de Janeiro, Rio de Janeiro, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT03920397",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 216, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -43,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Miami Baptist Hospital, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 220, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS",
                "aff": "Sanford Research, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04494386",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 220, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents",
                "aff": "Uppsala University Hospital, Uppsala, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT05061030",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 245, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2022-01-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03392311",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 232, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "SC Clinical Research, Garden Grove, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Diabetes Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Compass Research, Orlando, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Tulane University Medical Center, New Orleans, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Big Sky Clinical Research, Butte, Montana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -112,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Desert Endocrinology Clinical Research Center-Henderson, Henderson, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Alliance Against Diabetes/AAD Clinical Research, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Active Practices and Research, Newington, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Providence Health Partners - Center for Clinical Reseach, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Dallas Diabetes and Endocrine Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "West Houston Clinical Research Services, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Paragon Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Wasatch Clinical Research, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "National Clinical Research - Norfolk, Inc, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "National Clinical Research - Richmond, Inc., Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
                "aff": "Capital Clinical Research Center, Olympia, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01576328",
                "enrolled": 61,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 203, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2012-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "St Vincents Hospital, Sydney, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 201, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2017-04-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "The Prince Charles Hospital, Brisbane, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 201, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2017-04-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 201, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2017-04-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "The Alfred Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 201, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2017-04-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction",
                "aff": "Fiona Stanley Hospital, Murdoch, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02709343",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 201, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2017-04-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115,
                    -32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Seoul Nation University Bundang Hospital, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 244, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 244, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Korea University Anam Hospita, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 244, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 244, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05182034",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 244, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.",
                "aff": "Jinling hospital, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT04939337",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 223, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Reduce Immunosuppression With Atmp in NS ChildrEn",
                "aff": "Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, MI, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT04034316",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 204, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-10-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle",
                "aff": "Boston Children's Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03079401",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 210, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis",
                "aff": "Emeritus Research, Camberwell, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT05344157",
                "enrolled": 54,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 242, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2022-06-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis",
                "aff": "GWOXI Stem Cell Applied Technology Co., Ltd., Hsinchu, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03943576",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    24
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS",
                "aff": "Ruijin Hospital, Medical School of Shanghai Jiaotong University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04602104",
                "enrolled": 169,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 235, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2020-10-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection",
                "aff": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04544215",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 211, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines",
                "aff": "M D Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02962661",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 215, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2020-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients",
                "aff": "Christian von Buchwald, MD, DMSc, Professor, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT04776538",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 219, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-02-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Hospital, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Centers - BMT, Kansas City, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "The Cancer Center at Hackensack University, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mt. Sinai Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, FEC, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00136903",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05338099",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 216, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-01-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05333406",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 206, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Hospital S\u00e3o Rafael S.A. - Instituto D'Or de Pesquisa e Ensino, Salvador, BA, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 221, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -38,
                    -12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Santa Casa de Miseric\u00f3rdia da Bahia (Hospital Santa Izabel), Salvador, BA, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 221, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -38,
                    -12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Saraiva & Berlinger Ltda. - EPP (IPECC), Campinas, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 221, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -47,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "CECIP JAU - Centro de Estudos Cl\u00ednicos do Interior Paulista Ltda., Ja\u00fa, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 221, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -47,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "CEMEC - Centro Multidisciplinar de Estudos Cl\u00ednicos Ltda. - EPP, S\u00e3o Bernardo Do Campo, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 221, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -48,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress",
                "aff": "Impar Servi\u00e7os Hospitalares S/A (Hospital Nove de Julho), S\u00e3o Paulo, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04903327",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 221, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia",
                "aff": "Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01297972",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 240, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -53,
                    -10
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "Orthopaedic Associates of South Broward, PA, Hollywood, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "Sinai Hospital of Baltimore / Rubin Institute for Advanced Orthopedics, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "New Mexico Orthopedics, Albuquerque, New Mexico, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -106,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "OrthoCarolina Research Institute, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "Ohio Orthopedic Center of Excellence, Upper Arlington, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "The Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "University Orthopedics Center, State College, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "Central Tennessee Foot and Ankle Center, Sparta, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion",
                "aff": "Franciscan Foot and Ankle Specialists, Burien, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00988338",
                "enrolled": 106,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 215, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation",
                "aff": "Dr. Soetomo General Academic Hospital/ Department Orthopaedic & Traumatology Faculty of Medicine Universitas Airlangga, Surabaya, East Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04670302",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 248, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-09-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    112,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Emory University/Childen's Healthcare of Atlanta, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 207, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 207, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Johns Hopkins University Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 207, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 207, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)",
                "aff": "University of Utah/Heart Center-Primary Children's Hospital, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03525418",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 207, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT",
                "aff": "BMT department, Moscow, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT03389919",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 237, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    37,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke",
                "aff": "China Medical University Hospital, Taichung, Non-US, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04434768",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 240, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-05-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke",
                "aff": "Tri-Service General Hospital, Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04434768",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 240, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-05-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation",
                "aff": "St. Jude Children's Research Hospital, Memphis, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00705120",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 234, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "1995-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury",
                "aff": "Chinese PLA General Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04194671",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 201, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2021-11-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "CHU de Grenoble Hopital Albert Michallon, Grenoble, France",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "CHRU Lille- Hopital Claude Huriez, Lille, France",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "CHU de Nice Hopital Archet 1, Nice, France",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Centre Hospitalier Lyon Sud Pavillon Marcel Berard 1G, Pierre Benite Cedex, France",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Rennes, Rennes, France",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Centre Hospitalier Universitaire CHU de Toulouse, Toulouse, France",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Hopitaux De Brabois, Vandoeuvre les Nancy, France",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Klinikum rechts der Isar, Munich, Bavaria, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitaetsklinikum Wuerzburg - Medizinische Klinik und Poliklinik II - Zentrum fuer Allogene Blutstammzelltransplantation, W\u00fcrzburg, Bavaria, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Klinikum der Johann Wolfgang Goethe-Universitaet - Frankfurt am Main, Frankfurt am Main, Hessen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitatsklinikum Muenster, M\u00fcnster, Nordrhein-Westfalen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitaet Duisburg-Essen - Universitaetsklinikum Essen - Klinik fuer Knochenmarktransplantation (KMT), Essen, North Rhine-Westphalia, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Uniklinik Koeln, Koeln, North Rhine-Westphalia, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitatsklinikum Carl Gustav Carus Dresden, Dresden, Sachsen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Selbststandige Abteilung fur Hamatologie und Internistische Onkologie, Leipzig, Saxony, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitaetsklinikum Jena, Jena, Th\u00fcringen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitatsklinikum Jena, Jena, Th\u00fcringen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Charit Universitaetsmedizin Berlin, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "University Hospital Bonn, Medizinische Klinik III, Bonn, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitaetsklinikum Essen, Essen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Klinikum der Johann Wolfgang Goethe, Frankfurt, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universitatklinikum Freiburg, Freiburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "University Medical Center Mainz, Mainz, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Universit\u00c3\u00a4tsklinikum Mannheim, Mannheim, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "University Hospital Tuebingen Medical Center, Tuebingen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroc\u0142aw, Dolnoslaskie, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    16,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Hospital Universitario Vall dHebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Barcelona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Institut Catal dOncologia, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Hospital Germans Trias i Pujol, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Hospital Universitario Ramon y Cajal, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Hospital Puerta De Hierro, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Hospital Clinico Universitario de Valencia, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy",
                "aff": "Center for Allogeneic Stem Cell Transplantation and Cell Therapy (CAST), Karolinska Universitetssjukhuset Huddinge, Huddinge, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT04629833",
                "enrolled": 210,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis",
                "aff": "Universitair Medisch Centrum Utrecht, Utrecht, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT03211793",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 239, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-09-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 208, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa",
                "aff": "Sardjito Hospital, Yogyakarta, Special Region, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04315025",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 208, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)",
                "aff": "Cardiology PC, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00951210",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 226, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2009-01-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00951210",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 226, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2009-01-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells for Bronchopulmonary Dysplasia",
                "aff": "Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University, Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT03378063",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 232, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2017-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "REcycled CartiLage Auto/Allo IMplantation",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03672825",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 202, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05456243",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 232, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-07-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05075811",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 239, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-02-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Co-transplantation of MSC in the Setting of Allo-HSCT",
                "aff": "Union Hospital,Fujian Medical University, Fuzhou, Fujian, China",
                "url": "https://ClinicalTrials.gov/show/NCT04247945",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-02-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study for Participants Jointstem Clinical Trial",
                "aff": "KyungHee University Gangdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03509025",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 230, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-02-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study for Participants Jointstem Clinical Trial",
                "aff": "GangNam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03509025",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 230, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-02-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients",
                "aff": "Lakeridge Health, Oshawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04961658",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 240, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-07-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients",
                "aff": "St. Michael's Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04961658",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 240, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-07-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Univ.-Klinik Innsbruck, Innsbruck, Austria",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Krankenhaus, St. Veit/Glan, Austria",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    14,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Medizinische Universit\u00e4t, Wien, Austria",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    16,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Oost-Limburg, Genk, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Gent University Hospital, Gent, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Leuven University Hospital, Leuven, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Hartziekenhuis, Roeselare, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "CHU d'Amiens, Amiens, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "CHU de Bordeaux, Bordeaux, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "CHU de Caen, Caen, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "H\u00f4pital Beaujon, Clichy, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "CHRU de Lille, Lille, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "CHU de Marseille, Marseille, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "CHU de Nice, Nice, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "H\u00f4pital Saint-Louis, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Charite, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Krakenhaus Walfriede, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Klinikum Braunscheweig, Braunschweig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Klinikum Frankfurt, Frankfurt/Main, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Evangelisches Krankenhaus Kalk, K\u00f6ln, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Klinikum L\u00fcneburg, L\u00fcneburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Rambam MC, Haifa, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Sharee Zedek MC, Jerusalem, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Rabin MC, Petah Tikva, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Tel Aviv Sourasky MC, Tel Aviv, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Sheba MC, Tel Hashomer, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant'Orsola Malpighi, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Instituto Clinico Humanitas IRCCS, Milano, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Seconda Universit\u00e0 degli Studi di Napoli, Napoli, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    14,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Azienda Ospedaliera di Padova, Padova, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "AMC, Amsterdam, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "VUMC, Amsterdam, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Catharina Ziekenhuis, Eindhoven, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "UMCU, Utrecht, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital de Manises, Manises, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Clinic de Barcelona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Universitario Reina Sofia, Cordoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Juan Ramon Jimenez, Huelva, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -6,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Ram\u00f3n y Cajal, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Fundacion Jimenez Diaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital 12 de Octubre, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Clinico San Carlos, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital La Princesa, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Universitario La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Son Espases, Palma de Mallorca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital de Montecelo, Pontevedra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Virgen del Rocio, Seville, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital de Sagunto, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease",
                "aff": "Hospital Universitario La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01541579",
                "enrolled": 278,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 233, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2012-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "Sydney Local Health District, Sydney, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 221, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 221, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Bristol, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 221, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Trust, Leeds, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 221, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Liverpool, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 221, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Manchester, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 221, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease",
                "aff": "NHS Foundation Trust, Nottingham, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02923375",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 221, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia",
                "aff": "Franziskus-Krankenhaus, Berlin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT00919958",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 232, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2009-06-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital U. Central de Asturias, Oviedo, Asturias, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital General de M\u00e9rida, M\u00e9rida, Badajoz, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -6,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital U. de Canarias, La Laguna, Tenerife, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -16,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital de Cruces, Barakaldo, Vizcaya, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital de Basurto, Bilbao, Vizcaya, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Complejo Hospitalario U. A Coru\u00f1a, A Coru\u00f1a, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Vall d'Hebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Clinic i Provincial, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Santa Creu i Sant Pau, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Reina Sof\u00eda, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Cl\u00ednico San Cecilio, Granada, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital U. Virgen de las Nieves, Granada, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital U. de Guadalajara, Guadalajara, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital de La Princesa, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital U. Gregorio Mara\u00f1on, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Cl\u00ednico San Carlos, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital U. La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Carlos Haya, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital U. Marques de Valdecilla, Santander, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Ntra. S\u00aa de Valme, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",
                "aff": "Hospital Dr. Peset, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01663116",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 231, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans\u00ae",
                "aff": "Department of Cardiology, Respiratory medicine and Physiology, \u00d6rebro University Hospital, \u00d6rebro, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT04896853",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 199, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-05-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    16,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis",
                "aff": "Clinica Universidad de los Andes, Santiago, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT02580695",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 224, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria",
                "aff": "Celal Bayar University, Medical School, Manisa, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT02824393",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 219, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure",
                "aff": "Tianjin Weikai Bioeng., Ltd., Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT03863002",
                "enrolled": 45,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 214, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta",
                "aff": "Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02172885",
                "enrolled": 2,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2014-06-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta",
                "aff": "Hospital Universitario Getafe, Getafe, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02172885",
                "enrolled": 2,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2014-06-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy",
                "aff": "Yan'an Hospital of Kunming City, Kunming, China",
                "url": "https://ClinicalTrials.gov/show/NCT04125329",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 213, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    102,
                    24
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study",
                "aff": "Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan",
                "url": "https://ClinicalTrials.gov/show/NCT02482194",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 221, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-06-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 229, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease",
                "aff": "Shanghai General Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04414592",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 229, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02166489",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 222, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2014-06-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Knee Cartilage Injuries",
                "aff": "Cell Therapy Center, Jordan University Hospital, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT02118519",
                "enrolled": 13,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 233, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2014-04-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04446897",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 239, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-06-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction",
                "aff": "Asan medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02344849",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 217, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-01-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden",
                "aff": "Karolinska Institute, Karolinska University Hospital Solna, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03778333",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 214, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2012-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    18,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden",
                "aff": "Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03778333",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 214, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2012-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    18,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02492516",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 214, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-07-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells",
                "aff": "Uppsala University Hospital, Uppsala, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT01068951",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 243, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    17,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection",
                "aff": "Man Clinic for Andrology and male infertility, Cairo, Egypt",
                "url": "https://ClinicalTrials.gov/show/NCT02414295",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 217, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2013-04-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    31,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Fertility Restoration Using Autologous Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04432467",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 218, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells",
                "aff": "The Republican Center for Research and Practice in Otolaryngology, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT03130374",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 213, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-01-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells",
                "aff": "The Republican Research and Practical Center for Epidemiology and Microbiology, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT03130374",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 213, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-01-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2019-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Children's Hospital of Fudan University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2019-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)",
                "aff": "Shanghai First Maternity and Infant Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03645525",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2019-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT02963727",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 216, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-01-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT02966951",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 225, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells",
                "aff": "Hrodna City Clinical Hospital, Hrodna, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04446884",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 200, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    23,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study",
                "aff": "Health Sciences Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02239393",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 212, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-08-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study",
                "aff": "Ottawa Hospital - General Campus, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02239393",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 212, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-08-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies",
                "aff": "Ankara University School of Medicine Department of Hematology, Ankara, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT03106662",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 211, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2014-04-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    32,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01504464",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 223, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-01-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders",
                "aff": "Tianjin Medical University General Hospital, Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT02249676",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 205, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-08-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Hypoxia and Inflammatory Injury in Human Renovascular Hypertension",
                "aff": "University of Alabama, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02266394",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 215, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2014-09-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Hypoxia and Inflammatory Injury in Human Renovascular Hypertension",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02266394",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 215, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2014-09-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Hypoxia and Inflammatory Injury in Human Renovascular Hypertension",
                "aff": "University of Mississippi, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02266394",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 215, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2014-09-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Lung Rejection",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02181712",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 234, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-07-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety/Efficacy of hUC Mesenchymal Stem Cells\uff0819#iSCLife\u00ae-OA\uff09 Therapy for Patients With Osteoarthritis",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT03383081",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 199, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2018-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05345418",
                "enrolled": 158,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 210, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2022-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife\u00ae-LDP) for Lumbar Discogenic Pain",
                "aff": "Xuanwu Hospital Capital Medical University, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04104412",
                "enrolled": 242,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 243, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2019-08-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT01649700",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 217, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2011-07-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease",
                "aff": "Hebei Newtherapy BIo-Pharma Technology Co., Ltd, Shijiazhuang, Hebei, China",
                "url": "https://ClinicalTrials.gov/show/NCT03550183",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 231, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-01-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells and Subclinical Rejection",
                "aff": "Leiden Universitary Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT00734396",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 214, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2009-02-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital",
                "aff": "Emdai Kamyab Hospital, Mashhad, Khorasan, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01788059",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 215, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-02-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    59,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies",
                "aff": "University of Texas MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02804945",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 230, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT03343782",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 235, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01377870",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 210, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2011-06-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia",
                "aff": "University of Health Sciences, Istanbul, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04713878",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 204, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-05-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    29,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis",
                "aff": "Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT01809769",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 222, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Gingival Recession Using Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04434794",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 201, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05227846",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 248, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients",
                "aff": "Hospital e Maternidade Dr Christovao da Gama, Santo Andre, Sao Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT02987413",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2015-04-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients",
                "aff": "Instituto de Ensino e Pesquisas - IEP-S\u00e3o Lucas, Sao Paulo, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT02987413",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2015-04-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI",
                "aff": "The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02481440",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 225, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05331872",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 199, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "When to Apply to Which Patient in MSC?",
                "aff": "Trabzon Kanuni Training and Research Hospital, University of Healthy Sciences, Trabzon, Yomra, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT05240430",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 205, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2022-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    39,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease",
                "aff": "Li Yu, Shenzhen, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05152160",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 224, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Patients With Trophic Ulcers Using Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04457037",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 226, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05167721",
                "enrolled": 76,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 212, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2021-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-CSD) Therapy for Patients With Healing Poor After Uterus Injury",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT03386708",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 210, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02484950",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 220, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2015-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT05535803",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 212, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19",
                "aff": "Instituto de Medicina Regenerativa, Tijuana, Baja California, Mexico",
                "url": "https://ClinicalTrials.gov/show/NCT04456361",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 205, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-04-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04650568",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 248, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2017-10-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue",
                "aff": "Cl\u00ednica Universitaria de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01157650",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 217, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-07-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue",
                "aff": "Hospital Provincial de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01157650",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 217, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-07-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue",
                "aff": "Hospital Virgen del Camino, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01157650",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 217, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-07-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction",
                "aff": "Yonsei University Wonju College of Medicine, Wonju Christian Hospital, Wonju, Gangwon-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01392105",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 203, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2007-07-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction",
                "aff": "Inha University Hospital, Inchon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01392105",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 203, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2007-07-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction",
                "aff": "Yonsei Cardiovascular Center and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01392105",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 203, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2007-07-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19",
                "aff": "BioXcellerator, Medellin, Antioquia-CO, Colombia",
                "url": "https://ClinicalTrials.gov/show/NCT04390152",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 223, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-01-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19",
                "aff": "Clinical Somer, Rionegro, Antioquia, Colombia",
                "url": "https://ClinicalTrials.gov/show/NCT04390152",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 223, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-01-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study",
                "aff": "Hospital S\u00e3o Rafael, Salvador, Bahia, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT02152657",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 236, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2015-06-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -38,
                    -12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04426643",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 220, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04441658",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 209, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients",
                "aff": "University Hospital Virgen Macarena, Seville, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01257776",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 240, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients",
                "aff": "CABIMER (Andalusian Center for Molecular Biology and Regenerative Medicine), Seville, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01257776",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 240, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies",
                "aff": "Hospital Universitario A Coru\u00f1a, A Coru\u00f1a, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02443961",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 219, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-04-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies",
                "aff": "Hospital Cl\u00ednico San Carlos, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02443961",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 219, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-04-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies",
                "aff": "Hospital Universitario La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02443961",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 219, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-04-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies",
                "aff": "Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02443961",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 219, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-04-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Radiation-induced Xerostomia",
                "aff": "Department of Otolaryngology, University Hospital of Copenhagen, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT03876197",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 199, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",
                "aff": "Shanghai Sixth People's Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05468502",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-07-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect",
                "aff": "The Fifth Affiliated Hospital Immunotherapy center, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02291926",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 207, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction\uff08PRIME-HFrEF Study\uff09",
                "aff": "Heart Failure Department, East Hospital Affiliated to Tongji University, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04992832",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 222, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-07-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00850187",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 208, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2008-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee):",
                "aff": "Department of Orthopaedics & Traumatology, Hong Kong, Hong Kong",
                "url": "https://ClinicalTrials.gov/show/NCT04326985",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 205, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Ankle Joint Osteoartritis",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01436058",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 227, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2010-08-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04996966",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 243, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-01-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Rotator Cuff Repair",
                "aff": "Universidade de S\u00e3o Paulo, S\u00e3o Paulo, SP, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT03362424",
                "enrolled": 44,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 221, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Reconstruction of Jaw Bone Using Mesenchymal Stem Cells",
                "aff": "Institute of Clinical Dentistry, University of Bergen, Bergen, Hordaland, Norway",
                "url": "https://ClinicalTrials.gov/show/NCT02751125",
                "enrolled": 13,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 223, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2014-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    60
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT02981576",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 246, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2016-11-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04047810",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 204, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-01-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT05520125",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 230, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells",
                "aff": "Teknon Medical Center, ITRT, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01183728",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 204, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-05-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells",
                "aff": "Instituto de Biologia y Genetica Molecular (IBGM), University of Valladolid, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01183728",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 204, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-05-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 247, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 247, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 247, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u2122 Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease",
                "aff": "Osiris Clinical Site, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00294112",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 247, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2006-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03745417",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 230, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2021-10-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT05520112",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 219, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "UZA, Edeghem, Antwerpen, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "H\u00f4pital des enfants Reine Fabiola, Brussels, Brabant, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "AZ VUB Jette, Brussels, Brabant, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "Cliniques universitaires Saint-Luc- Universit\u00e9 Catholique de Louvain, Brussels, Brabant, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "AZ Gasthuisberg Leuven, Leuven, Flamish Brabant, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "UZ Gent, Gent, Flanders Ost, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "H\u00f4pital de Jolimont, Haine St Paul, Hainaut, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "Cliniques Universitaires Mont-Godinne, Yvoir, Namur, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "AZ St Jan, Brugge, West Flanders, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "H\u00f4pital Stuyvenberg, Antwerpen, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "CHU Sart Tilman, Liege, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function",
                "aff": "University Hospital Maastricht, Maastricht, Limburg, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT00603330",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2008-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.",
                "aff": "Hospital San Lazaro, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01745744",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 220, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2011-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.",
                "aff": "University Hospital Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01745744",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 220, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2011-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients",
                "aff": "Istinye University, Istanbul, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04898088",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 208, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients",
                "aff": "SB\u00dc Dr. Sadi Konuk E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Istanbul, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04898088",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 208, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01609283",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 250, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-05-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients",
                "aff": "Hospital S\u00edrio Liban\u00eas, S\u00e3o Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01932164",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 209, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2013-05-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -53,
                    -10
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis",
                "aff": "Stem Cell Institute, Panama City, Panama",
                "url": "https://ClinicalTrials.gov/show/NCT02034188",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 223, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-01-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    8
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis",
                "aff": "Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01056471",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 230, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-01-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis",
                "aff": "Hospital Universitario Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01056471",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 230, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-01-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy",
                "aff": "Hospital Universitario La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01824069",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 225, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-04-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19",
                "aff": "RSUPN Dr. Cipto Mangunkusumo, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05122234",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 203, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19",
                "aff": "RSUP Fatmawati, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05122234",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 203, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19",
                "aff": "RSUP Persahabatan, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05122234",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 203, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19",
                "aff": "Rumah Sakit Universitas Indonesia, Depok, Jawa Barat, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05122234",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 203, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS",
                "aff": "JST sp. z o.o., Cz\u0119stochowa, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT04651855",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 242, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease",
                "aff": "Shanghai East Hospital, Shanghai, Pudong New Area, China",
                "url": "https://ClinicalTrials.gov/show/NCT05262829",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 207, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-02-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP",
                "aff": "KyungHee University Gandong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03979898",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 202, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2017-06-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair",
                "aff": "Centro de Tecnologia Celular, Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Curitiba, Paran\u00e1, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01895413",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 248, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-07-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -40,
                    -20
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-UT) Therapy for Patients With Thin Endometrial Infertility",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05495711",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 217, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells to Treat Type 2 Diabetes",
                "aff": "Chinese PLA General Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02302599",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 242, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2013-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke",
                "aff": "Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04811651",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 214, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    123,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously",
                "aff": "Asan medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04594850",
                "enrolled": 54,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 204, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-09-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously",
                "aff": "Samsung medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04594850",
                "enrolled": 54,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 204, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-09-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously",
                "aff": "Seoul ST. Mary's hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04594850",
                "enrolled": 54,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 204, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-09-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",
                "aff": "H. Juan Ram\u00f3n Jim\u00e9nez, Huelva, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02292628",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 206, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -6,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",
                "aff": "Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02292628",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 206, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",
                "aff": "Hospital Regional U de M\u00e1laga, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02292628",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 206, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",
                "aff": "Hospital U Virgen del Rocio, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02292628",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 206, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04520373",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 244, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe Infections With Mesenchymal Stem Cells",
                "aff": "Service de R\u00e9animation M\u00e9dicale, H\u00f4pital Bocage, Dijon, France",
                "url": "https://ClinicalTrials.gov/show/NCT02883803",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2019-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe Infections With Mesenchymal Stem Cells",
                "aff": "Service de R\u00e9animation M\u00e9dicale, H\u00f4pital Central, Nancy, France",
                "url": "https://ClinicalTrials.gov/show/NCT02883803",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2019-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe Infections With Mesenchymal Stem Cells",
                "aff": "H\u00f4pital Hautepierre, Service de r\u00e9animation m\u00e9dicale, Strasbourg, France",
                "url": "https://ClinicalTrials.gov/show/NCT02883803",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2019-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe Infections With Mesenchymal Stem Cells",
                "aff": "UTCT, H\u00f4pital Brabois, Vandoeuvre-les-Nancy, France",
                "url": "https://ClinicalTrials.gov/show/NCT02883803",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2019-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Age-Related Frailty",
                "aff": "Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05284604",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 202, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-09-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration",
                "aff": "CHA University, CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05011474",
                "enrolled": 4,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 239, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2021-04-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Angiographic Delivery of AD-MSC for Ulcerative Colitis",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04312113",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 234, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty",
                "aff": "Shanghai East Hospital, Shanghai Tongji University, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04314011",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 202, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05329662",
                "enrolled": 130,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 246, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2022-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02277145",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 233, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2014-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.",
                "aff": "Ribeir\u00e3o Preto Medical School, Ribeirao Preto, Sao Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT02330978",
                "enrolled": 2,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 232, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2014-01-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -47,
                    -21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome",
                "aff": "M D Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04565665",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 225, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2020-07-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis",
                "aff": "Servicio de Neumolog\u00eda, Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01919827",
                "enrolled": 17,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 212, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-03-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis",
                "aff": "Servicio de Neumolog\u00eda. Hospital Universitario de Salamanaca, Salamanca, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01919827",
                "enrolled": 17,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 212, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-03-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "First Affiliated Hospital of the Third Military University, PLA (Southwest Hospital), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 219, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells",
                "aff": "Nanjing Chest Hosptial, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02668068",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 219, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells (MSC) for Ovarian Cancer",
                "aff": "University of Texas MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02530047",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 245, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2016-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis",
                "aff": "Cell Therapy Center, Jordan University Hospital, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT01895439",
                "enrolled": 13,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 216, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-07-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS",
                "aff": "Cleveland Clinic Mellen Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00813969",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 222, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2011-11-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells and Myocardial Ischemia",
                "aff": "University Hospital (Rangueil), Toulouse, France",
                "url": "https://ClinicalTrials.gov/show/NCT01076920",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2009-02-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Impact of Mesenchymal Stem Cells in Knee Osteoarthritis",
                "aff": "University Hospital Cleveland Medical Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03477942",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 206, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells After Renal or Liver Transplantation",
                "aff": "University Hospital Liege, Liege, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT01429038",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 226, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2012-02-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 247, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
                "aff": "PT Prodia StemCell Indonesia, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05008588",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 247, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy",
                "aff": "Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00911365",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 244, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2008-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01759797",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 244, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2013-01-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis",
                "aff": "Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02035514",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 243, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Stem Cells for Traumatic Spinal Cord Injury",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03308565",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 239, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-11-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01771640",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 205, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2013-01-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells",
                "aff": "Ankara University Biotechnology Institute, Ankara, T\u00fcrkiye, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04224207",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 227, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells",
                "aff": "Umut Arslan, Ankara, T\u00fcrkiye, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04224207",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 227, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01142856",
                "enrolled": 1,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 236, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2010-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection",
                "aff": "Osaka University Hospital, Suita, Osaka, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT04522986",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 249, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2020-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    135,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa",
                "aff": "Erciyes University, Faculty of Medicine, Kayseri, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT05413148",
                "enrolled": 135,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 242, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2022-06-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)",
                "aff": "R\u00edo Hortega University Hospital, Valladolid, Valladid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01389661",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 239, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-07-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)",
                "aff": "Bionand, Parque Tecnol\u00f3gico de Andaluc\u00eda, Universidad de M\u00e1laga, Malaga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01389661",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 239, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-07-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)",
                "aff": "Instituto de Biologia y Genetica Molecular, Valladolid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01389661",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 239, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-07-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction",
                "aff": "The Third Hospital of Mianyang, Mianyang, Sichuan, China",
                "url": "https://ClinicalTrials.gov/show/NCT04421274",
                "enrolled": 43,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 200, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2008-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    104,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02808208",
                "enrolled": 74,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 247, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2017-06-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells for Uremic Calciphylaxis Patients",
                "aff": "The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT04592640",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 230, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2018-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial",
                "aff": "Research Center for Gastroenterology and Liver Diseases, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00420134",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 225, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2006-01-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial",
                "aff": "Research center of Gastroenterology and Liver Disease, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00420134",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 225, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2006-01-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT03945487",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 213, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2019-05-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease",
                "aff": "Seoul St. Mary's Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01302015",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 217, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2007-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease",
                "aff": "SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01302015",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 217, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2007-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients",
                "aff": "Gang Li, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04093336",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 241, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-01-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama at Birmingham, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Arizona Cancer Center, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "City of Hope, Duarte, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of California San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Yale New Haven Hospital, New Haven, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "All Children's Hospital, Saint Petersburg, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Illinois - Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana Blood and Bone Marrow Transplant Center, Beech Grove, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Kansas Medical Center, Kansas City, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Louisiana State University, Shreveport, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Maryland/Greenbaum, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts-New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana-Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Karmanos/Wayne State University, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Clinic Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Nebraska, Omaha, Nebraska, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hackensack University Medical Center, Hackensack, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Columbia University/New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Rochester, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Medical College, Valhalla, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest Univeristy School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oregon Health and Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Cancer Center at Medical City, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Univeristy of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Research Center, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth/Massey Cancer Center, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Wisconsin Madison, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Co-Medica Research Network, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "British Columbia's Children's Hospital, Vancouver, British Columbia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -123,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Cancer Care Manitoba, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -63,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hamilton Health Sciences Centre, Hamilton, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "London Health Sciences Centre- Westminster Campus, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Toronto General Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital Enfant-Jesus, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Hopital du Saint-Sacrement, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Universia degli Studi di Pesaro, Pesaro, PU, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "IRCCS Policlinico San Matteo, Pavia, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kantonsspital Basel, Basel, Switzerland",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barts & London School of Medicine, London, England, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "John Radcliffe Hospital, Headington, Oxford, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Bristol Royal Hospital for Children, Bristol, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Glasgow Royal Infirmary, Glasgow, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)",
                "aff": "Leeds General Infirmary, Leeds, UK, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00366145",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 224, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2006-01-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia",
                "aff": "Yunfei Chen, Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT04014166",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 207, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04061746",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 221, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-02-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02068794",
                "enrolled": 57,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 223, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-03-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures",
                "aff": "Hadassah Medical Organizaton, Jerusalem, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT00250302",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 228, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-10-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Wharton Jelly in Erectile Dysfunction",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT03751735",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 241, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-01-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)",
                "aff": "University hospital of Henri Mondor, Cr\u00e9teil, France",
                "url": "https://ClinicalTrials.gov/show/NCT02462330",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-02-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)",
                "aff": "University hospital of Grenoble, Grenoble, France",
                "url": "https://ClinicalTrials.gov/show/NCT02462330",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-02-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)",
                "aff": "University hospital of Lille, Lille, France",
                "url": "https://ClinicalTrials.gov/show/NCT02462330",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-02-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)",
                "aff": "University hospital of Nantes, Nantes, France",
                "url": "https://ClinicalTrials.gov/show/NCT02462330",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-02-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)",
                "aff": "University hospital of Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02462330",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-02-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)",
                "aff": "Cardiology Department of Rangueil Hospital - Rangueil Hospital, Toulouse, France",
                "url": "https://ClinicalTrials.gov/show/NCT02462330",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-02-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells",
                "aff": "University Hospital of Salamanca, Salamanca, Castilla y Le\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01700920",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 232, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2012-09-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT00823316",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 209, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2008-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intravenous Stem Cells After Ischemic Stroke",
                "aff": "Neuroradiology/MRI, University Hospital of Grenoble, Grenoble, France",
                "url": "https://ClinicalTrials.gov/show/NCT00875654",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 234, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-04-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intravenous Stem Cells After Ischemic Stroke",
                "aff": "Stroke Unit, University Hospital of Grenoble, Grenoble, France",
                "url": "https://ClinicalTrials.gov/show/NCT00875654",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 234, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-04-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intravenous Stem Cells After Ischemic Stroke",
                "aff": "Tissular and cell therapy unit, UniversityHospitalof Grenoble, Grenoble, France",
                "url": "https://ClinicalTrials.gov/show/NCT00875654",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 234, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-04-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC-Exos Promote Healing of MHs",
                "aff": "Tianjin Medical University Hospital, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT03437759",
                "enrolled": 44,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 214, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis",
                "aff": "University hospital of North Norway, Troms\u00f8, Troms Og Finnmark, Norway",
                "url": "https://ClinicalTrials.gov/show/NCT04749667",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-02-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    18,
                    69
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis",
                "aff": "St.Olav university hospital, Trondheim, Tr\u00f8ndelag, Norway",
                "url": "https://ClinicalTrials.gov/show/NCT04749667",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-02-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    60
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis",
                "aff": "Haukeland University Hospital, Bergen, Vestland, Norway",
                "url": "https://ClinicalTrials.gov/show/NCT04749667",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-02-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    60
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis",
                "aff": "Akershus university hospital, L\u00f8renskog, Viken, Norway",
                "url": "https://ClinicalTrials.gov/show/NCT04749667",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-02-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC for Occlusive Disease of the Kidney",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01840540",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 245, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2013-04-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application",
                "aff": "Pediatric Surgery Department, King Edward Medical University, Lahore, Punjab, Pakistan",
                "url": "https://ClinicalTrials.gov/show/NCT04219657",
                "enrolled": 110,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2016-09-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Wharton Jelly in Erectile Dysfunction",
                "aff": "Cell Therapy Center, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT02945449",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 239, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-01-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03840343",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 207, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-09-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01873625",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 222, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2009-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury",
                "aff": "Qilu hospital of Shandong University, Jinan, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03955497",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 238, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease",
                "aff": "Trauma Service. Hospital Universitario de Salamanca, Salamanca, Castilla-Le\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01513694",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-01-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019",
                "aff": "Fuzhou General Hospital, Fuzhou, Fujian, China",
                "url": "https://ClinicalTrials.gov/show/NCT04371601",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 210, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05308836",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 222, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-09-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium",
                "aff": "Sir Run Run Shaw hopital,School of medicine,Zhejiang University, Hangzhou, China",
                "url": "https://ClinicalTrials.gov/show/NCT03724617",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 247, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-09-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC for Treatment of cGVHD After Allo-HSCT",
                "aff": "Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT04692376",
                "enrolled": 152,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 218, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2021-01-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage",
                "aff": "Mayo Clinic in Florida, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03371329",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 208, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-11-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells",
                "aff": "Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04484402",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 228, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-09-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of UC-MSC Transfusion for ACLF Patients",
                "aff": "Ren Ji Hospital, School of Medicine, Shanghai Jiao TongUniversity,, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04822922",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 217, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-08-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome",
                "aff": "Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France",
                "url": "https://ClinicalTrials.gov/show/NCT04625738",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 202, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-10-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer",
                "aff": "National Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing, Beiijng, China",
                "url": "https://ClinicalTrials.gov/show/NCT04464213",
                "enrolled": 43,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 242, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    104,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury",
                "aff": "Korea University Anam Hospital, Seoul, Seongbukgu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01624779",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 233, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-06-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hUC Mesenchymal Stem Cells (19#iSCLife\u00ae-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis",
                "aff": "Xiangya Hospital Central South University, Changsha, Hunan, China",
                "url": "https://ClinicalTrials.gov/show/NCT03826433",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 210, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02398370",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 217, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2013-03-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD",
                "aff": "Z Urology, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02395029",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 216, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2013-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)",
                "aff": "University of Cambridge Dept of Clinical Neurosciences, Cambridge, Cambridgeshire, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00395200",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 202, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2008-10-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)",
                "aff": "University College London Institute of Neurology, London, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT00395200",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 202, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2008-10-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of ADR-001 in Patients With Liver Cirrhosis",
                "aff": "Niigata University Medical & Dental Hospital, Niigata, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT03254758",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 239, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-07-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of ADR-001 in Patients With Liver Cirrhosis",
                "aff": "Nihon University Itabashi Hospital, Tokyo, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT03254758",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 239, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-07-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    139,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells for Treating HBV Clinical Study",
                "aff": "Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05442437",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 219, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-08-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair",
                "aff": "Hospital S\u00edrio-Libanes, S\u00e3o Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT03766217",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 246, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2019-04-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -53,
                    -10
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip Joint",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01499056",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 235, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2010-11-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy in Multiple System Atrophy",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02315027",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 233, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03181087",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 236, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis",
                "aff": "Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02888704",
                "enrolled": 13,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 243, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2016-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants",
                "aff": "National Chen-Kung University Hospital, Tainan City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03631420",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 215, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)",
                "aff": "Osaka University Hospital, Suita, Osaka, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT04888949",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 248, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-06-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    135,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase \u2161 Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Venous Leg",
                "aff": "Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05319106",
                "enrolled": 76,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 244, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2022-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD",
                "aff": "Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT04213248",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 202, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "CHU Clermont-Ferrand, Clermont-Ferrand, France",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Department of Orthopaedic Surgery, Hospital Henri Mondor, Cr\u00e9teil, France",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Department of Orthopaedic Surgery, CHU Nantes, Nantes, France",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Department of Orthopaedic Surgery Toulouse University Hospital, Toulouse, France",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Department of Orthopaedic Surgery, CHU Tours, Tours, France",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Universit\u00e4tsklinikum Frankfurt, Department of Trauma, Hand and Reconstructive Surgery, Frankfurt, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Universit\u00e4tsklinikum Freiburg, Klinik f\u00fcr Orthop\u00e4die und Unfallchirurgie, Freiburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Universit\u00e4tsklinikum M\u00fcnchen, Munich, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Department of Orthopaedic Trauma, University of Ulm, Ulm, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Istituto Ortopedico Rizzoli, SSD Fisiopatologia Ortopedica e Medicina Rigenerativa, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Arienda Spedali Civili di Brescia II Ortopedia e Traumatologia, Brescia, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Istituto Ortopedico Galeazzi, Chirugia dell\u00b4Anca l, Milano, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Hospital U. Puerta de Hierro-Majadahonda, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda, Majadahonda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Hospital Cl\u00ednica San Carlos, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Hospital U. 12 de Octubre, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Hospital U. Gregorio Mara\u00f1on, Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Hospital U. La Princesa, Servicio de Cirug\u00edaOrtop\u00e9dica y Traumatolog\u00eda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union",
                "aff": "Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda \"A\", Hospital La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03325504",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 211, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients",
                "aff": "Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05499156",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 236, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2022-01-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "ATCell\u2122 Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion",
                "aff": "BioSolutions Clinical Research Center, La Mesa, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04744051",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 204, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-02-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy",
                "aff": "Uhmontpellier, Montpellier, France",
                "url": "https://ClinicalTrials.gov/show/NCT05187936",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 247, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells in Rapidly Evolving Active Multiple Sclerosis",
                "aff": "Imperial College Healthcare NHS Trust, London, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT01606215",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 245, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-05-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Al-Zahra Heart Hospital, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 247, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Faghihi Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 247, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs for Prevention of MI-induced HF",
                "aff": "Namazee Hospital, Shiraz, Fars, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05043610",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 247, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    54,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis",
                "aff": "Peking Union Medical College Hospital (Dongdan campus), Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04971980",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 202, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.",
                "aff": "Universidad de los Andes, Santiago, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT03102879",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 248, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -70,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease",
                "aff": "Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China",
                "url": "https://ClinicalTrials.gov/show/NCT05531266",
                "enrolled": 182,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 241, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2022-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Kangwon National University Hospital, Chuncheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Chungnam National University Hospital, Chungnam, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Chonnam National University Hospital, Gwangju, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Yongin Severance Hospital, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Gachon University Gil Medical Center, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Catholic University of Korea, Seoul ST. Mary's Hospital., Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Korea University Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction.",
                "aff": "Wonju Severance Christian Hospital, W\u014fnju, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01652209",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2013-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "The First Hospital of Lanzhou University, Lanzhou, Gansu, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 207, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2022-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Hainan hospital of Chinese PLA General Hospital, Sanya, Hainan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 207, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2022-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    109,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Jin Yin-tan hospital, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 207, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2022-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Renmin Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 207, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2022-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Shanghai Changzheng Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 207, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2022-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05224960",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 207, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2022-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "The First Hospital of Lanzhou University, Lanzhou, Gansu, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 230, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Hainan hospital of Chinese PLA General Hospital, Sanya, Hainan, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 230, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    109,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Renmin Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 230, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Shanghai Changzheng Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 230, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT05121870",
                "enrolled": 240,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 230, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CD49 in Optimization The Cologenicity of Mesenchymal Stem Cell Culture Passage",
                "aff": "Sohag University Hospital, Sohag, Egypt",
                "url": "https://ClinicalTrials.gov/show/NCT05093725",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 227, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    32,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis",
                "aff": "The Prince Charles Hospital, Brisbane, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01385644",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 246, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2010-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)",
                "aff": "General Hospital of Central Theater Command, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04288102",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 207, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)",
                "aff": "Maternal and Child Hospital of Hubei Province, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04288102",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 207, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)",
                "aff": "Wuhan Huoshenshan Hospital, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT04288102",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 207, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Safety and The Efficacy Evaluation of NEUROSTEM\u00ae-AD in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297218",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 231, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer",
                "aff": "the southwest Hospital, Chongqing, Chongqing, China",
                "url": "https://ClinicalTrials.gov/show/NCT00955669",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 233, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2009-01-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Arizona Heart Institute, Phoenix, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -112,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "University of California - San Diego; Thornton, San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Washington Hospital Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "The Care Group, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Jewish Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Johns Hopkins University, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Washington Adventist, Takoma Park, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Columbia Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "University of Rochester - Strong Memorial, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Austin Heart Institute, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction",
                "aff": "Texas Medical School, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00114452",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 235, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of PNEUMOSTEM\u00ae in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02381366",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 243, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE\u00ae) TO HEAL CHRONIC DIABETIC FOOT ULCERS",
                "aff": "University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04104451",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 204, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-10-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis",
                "aff": "Stanley C Jones, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04448106",
                "enrolled": 300,
                "radius": 27,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 249, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9973,
                "paneLabel": "pane9973",
                "start": "2022-08-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects",
                "aff": "Dental School, Aristotle University, Thessaloniki, Greece",
                "url": "https://ClinicalTrials.gov/show/NCT02449005",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 214, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-05-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    22,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells: Alterations in Genome",
                "aff": "nantes University Hospital, Nantes, France",
                "url": "https://ClinicalTrials.gov/show/NCT00836732",
                "enrolled": 35,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 225, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2008-02-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts",
                "aff": "Stem cell therapy center,Fuzhou General Hospital, Fuzhou, Fujian, China",
                "url": "https://ClinicalTrials.gov/show/NCT00658073",
                "enrolled": 165,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 207, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2008-04-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis",
                "aff": "Shanghai Liver Disease Research Center, the Nanjing Military Command (Shanghai 85 Hospital), Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT01342250",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 201, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-04-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury",
                "aff": "Korea University Anam Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01769872",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 216, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction",
                "aff": "Asan medical center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03933995",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 205, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-03-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Transplantation for Osteoarthritis",
                "aff": "Yantai Yuhuangding Hospital, Yantai, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT03969680",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 208, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2019-07-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intravitreal Injection of MSCs in Retinitis Pigmentosa",
                "aff": "Siriraj Hospital Mahidol University, Bangkoknoi, Bangkok, Thailand",
                "url": "https://ClinicalTrials.gov/show/NCT01531348",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 217, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-02-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    100,
                    13
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy",
                "aff": "Memorial Hermann Hospital-Clinical Research Unit (MMH-CRU), Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04063215",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 229, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Soonchunhyang University Hospital, Bucheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Soonchunhyang University Hospital, Cheonan, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Gangwon National University Hospital, ChunCheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Hallym Univ. Medical Center, ChunCheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Gangneung Asan Hospital, Gangneung-si, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    128,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Eunpyeong St. Mary's Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Korea University Anam Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Soonchunhyang University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Wonju Severance Christian Hospital, Wonju, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis",
                "aff": "Yongin Severance Hospital, Yongin, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04689152",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2021-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Alabama, Division of Endocrinology & Metabolism, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Scripps Whittier Diabetes Institute, La Jolla, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Stanford University, Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Diabetes Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Kentucky, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Minnesota, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Desert Endocrinology CRC, Henderson, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Nevada Alliance Against Diabetes, Las Vegas, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of North Carolina Diabetes Care Center, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "American Health Research, Inc., Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Lindner Clinical Trial Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Providence Health Partners - Center for Clinical Research, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Cumberland Valley Endocrinology, Carlisle, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "AM Diabetes & Endocrinology Center, Bartlett, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The University of Texas Southwestern Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Optimum Clinical Research, Inc., Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "The Strelitz Diabetes Center, Eastern VA Medical School, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "University of Wisconsin Health- West Clinic, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u00ae (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)",
                "aff": "Clinical and Transitional Science Institute, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00690066",
                "enrolled": 63,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers",
                "aff": "Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT04313647",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 244, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-03-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Clinical Trial of ADR-001 for IgA Nephropathy",
                "aff": "Kasugai Municipal Hospital, Kasugai, Aichi, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT04342325",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 234, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-06-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    137,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Clinical Trial of ADR-001 for IgA Nephropathy",
                "aff": "Nagoya University Hospital, Nagoya, Aichi, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT04342325",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 234, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-06-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    136,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Steroid Resistant GVHD by Infusion MSC",
                "aff": "UMC Utrecht, department of pediatrics, Utrecht, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT00827398",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 238, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2009-01-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Steroid Resistant GVHD by Infusion MSC",
                "aff": "UMCU department of Haematology, Utrecht, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT00827398",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 238, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2009-01-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)",
                "aff": "Fu Cheng Lu 6, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT01291329",
                "enrolled": 160,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 245, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2011-02-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02941666",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 213, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-09-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research",
                "aff": "SAHZU, Hanzhou, Zhejiang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04951882",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 242, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-06-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3\u30014 )",
                "aff": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05512988",
                "enrolled": 44,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 219, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-04-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure",
                "aff": "Stanford University School of Medicine (Falk Cardiovascular Research Center), Stanford, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02501811",
                "enrolled": 125,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 234, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2015-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure",
                "aff": "University of Florida-Department of Medicine, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02501811",
                "enrolled": 125,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 234, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2015-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure",
                "aff": "University of Miami-Interdisciplinary Stem Cell Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02501811",
                "enrolled": 125,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 234, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2015-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure",
                "aff": "Indiana Center for Vascular Biology and Medicine, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02501811",
                "enrolled": 125,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 234, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2015-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02501811",
                "enrolled": 125,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 234, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2015-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure",
                "aff": "Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02501811",
                "enrolled": 125,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 234, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2015-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure",
                "aff": "Texas Heart Institute, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02501811",
                "enrolled": 125,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 234, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2015-07-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula",
                "aff": "Division of Colorectal Surgery, Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05402748",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 216, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2021-11-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head",
                "aff": "SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01643655",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 202, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-07-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency",
                "aff": "Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT05308342",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 224, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2019-10-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploratory Efficacy Study of NEUROSTEM\u00ae in Subjects Who Control Group of NEUROSTEM\u00ae",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04954534",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 204, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-07-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis",
                "aff": "SMG-SNU Boramae Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01300598",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 234, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2008-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Patients Diagnosed With COVID-19",
                "aff": "Hospital Regional Lic Adolfo Lopez Mateos, Mexico City, Ciudad De Mexico CDMX (Mexico City), Mexico",
                "url": "https://ClinicalTrials.gov/show/NCT04611256",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 245, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -99,
                    19
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02968459",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 246, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-10-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells",
                "aff": "Yantai Yuhuangding Hospital, Yantai, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT04212728",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 230, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2019-11-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)",
                "aff": "Pharmicell Co., Ltd., Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01875081",
                "enrolled": 72,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 249, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2012-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells (MSCs) - Like Cell Transplantation in Women With Primary Ovarian Insufficiency",
                "aff": "The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China",
                "url": "https://ClinicalTrials.gov/show/NCT03877471",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 206, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-04-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury",
                "aff": "Hospital de Neurorehabilitaci\u00f3 Institut Guttmann, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT03003364",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 202, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2016-11-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia",
                "aff": "RSUD Bantul, Bantul, Central Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04753476",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia",
                "aff": "RS PKU Muhammadiyah Gamping, Yogyakarta, Central Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04753476",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia",
                "aff": "RS Primaya Bekasi Timur, Bekasi, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04753476",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia",
                "aff": "Bhayangkara Hospital, Makassar, South Celebes, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04753476",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119,
                    -5
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia",
                "aff": "Gatot Soebroto Army Hospital, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04753476",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia",
                "aff": "Dr. Esnawan Antariksa Air Force Hospital, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04753476",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 220, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-06-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04349631",
                "enrolled": 56,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 216, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-04-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Parkinson's Disease Therapy Using Cell Technology",
                "aff": "the Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04146519",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 234, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2017-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy",
                "aff": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02635464",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 207, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-11-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Maryland, Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Chevy Chase Clinical Research, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Royal Melbourne Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Health Science Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "University of Otago, Christchurch, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    172,
                    -43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease",
                "aff": "Waikato Hospital, Hamilton, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT00482092",
                "enrolled": 330,
                "radius": 28,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9972,
                "paneLabel": "pane9972",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    175,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures",
                "aff": "D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology, Saint Petersburg, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT03166189",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 211, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2017-11-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    30,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial",
                "aff": "UC Davis Health, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04652908",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 228, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-06-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock",
                "aff": "Erciyes University, Kayseri, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT05283317",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 227, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-03-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of UC-MSCs for COVID-19 Patients",
                "aff": "Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04355728",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 240, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-04-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)",
                "aff": "Renmin Hospital of Wuhan University, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05507762",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 218, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-07-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis",
                "aff": "Hadassah Medical Organization, Jerusalem, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT02166021",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 204, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2015-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Efficacy of Exosome in Degenerative Meniscal Injury",
                "aff": "Eskisehir Osmangazi University, Eskisehir, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT05261360",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 236, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2022-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    30,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "An Follow-Up Study of Liver Cirrhosis",
                "aff": "Niigata University Medical & Dental Hospital, Niigata, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT03472742",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 219, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-03-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pilot Study of Stem Cell Treatment of Patients With Vocal Fold Scarring",
                "aff": "Karolinska University Hospital, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT01981330",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 226, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2012-10-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    18,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Evaluation of PNEUMOSTEM\u00ae Treatment in Premature Infants With Bronchopulmonary Dysplasia",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01297205",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 245, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis",
                "aff": "Tisch MS Research Center of New York, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03355365",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 228, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2018-08-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2B Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis",
                "aff": "Department of Orthopedic & Traumatology, Faculty of Medicine, Hospital Canselor Tuanku Mukhriz, UKM Medical Centre, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, 56000 Kuala Lumpur., Cheras, Kuala Lumpur, Malaysia",
                "url": "https://ClinicalTrials.gov/show/NCT04520945",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 237, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-09-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    101,
                    3
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of COVID-19",
                "aff": "Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04573270",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 210, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-04-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Progenitor Potential of Mesenchymal Stem Cells in Palatal Tissue Harvested From Molar and Premolar Sites",
                "aff": "UAB School of Dentistry Department of Periodontology, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03570333",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 223, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Advanced Clinical Research Institute, Anaheim, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Veteran's Administration Medical Center (does not require vet status), Long Beach, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Southern California University Hospital, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Western States Clinical Research, Wheat Ridge, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of Connecticut, Hamden, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Borland-Groover Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Venture Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Atlanta Gastroenterology Associates, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Chicago Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Carle Clinic Association, Urbana, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Indiana University Medical Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Kentucky Hospital, Lexington, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Louisville Hospital, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gulf Coast Research, Baton Rouge, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "National Institutes of Health, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Metropolitan Gastroenterology Group, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Brigham and Womens Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Clinical Pharmacology Study Group, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Clinical Studies, Dearborn, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Center for Digestive Health, Troy, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Minnesota Hospital, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "St Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Research Associates, Cedar Knolls, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Holy Name Hospital, Teaneck, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester Institute for Digestive Diseases, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Rochester General Hospital, Rochester, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University Hospital and Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Charlotte Gastroenterology and Hepatology, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Pinehurst Medical Clinic, Pinehurst, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Wake Forest University, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Dayton Science Institute, Dayton, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology United of Tulsa, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Options Health Research, Tulsa, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Allegheney Center for Digestive Health, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Nashville GI Specialists, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Texas Medical Branch, Galveston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Memorial Hermann Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Digestive and Liver Disease Specialists, Norfolk, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Seattle Gastroenterology Associates, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Calgary, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -114,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "University of Alberta Hospital, Edmonton, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Health Sciences Centre, Winnipeg, Manitoba, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "London Health Sciences Centre, London, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease",
                "aff": "Mount Sinai Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00543374",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 201, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03799718",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 227, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS",
                "aff": "Stanford University School of Medicine, Redwood City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03799718",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 227, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS",
                "aff": "The Mount Sinai Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03799718",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 227, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03799718",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 227, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.",
                "aff": "Paulo Roberto Slud Brofman, Curitiba, Paran\u00e1, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT05433298",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 209, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2022-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -40,
                    -20
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Cartilage Defects With Peripheral Blood Stem Cells",
                "aff": "Institute of Sports Medicine, Peking University Third Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04953572",
                "enrolled": 252,
                "radius": 25,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 228, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9975,
                "paneLabel": "pane9975",
                "start": "2021-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis",
                "aff": "Tisch MS Research Center of New York, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01933802",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 245, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-08-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells",
                "aff": "Nantes University Hospital, Nantes, France",
                "url": "https://ClinicalTrials.gov/show/NCT01879046",
                "enrolled": 35,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 210, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-06-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cord Blood Expansion on Mesenchymal Stem Cells",
                "aff": "University of Texas MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00498316",
                "enrolled": 98,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 237, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-07-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Safety and Exploratory Efficacy of CARTISTEM\u00ae, a Cell Therapy Product for Articular Cartilage Defects",
                "aff": "Cartilage Restoration Center; RUSH University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01733186",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 236, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Safety and Exploratory Efficacy of CARTISTEM\u00ae, a Cell Therapy Product for Articular Cartilage Defects",
                "aff": "Cartilage Repair Center; Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01733186",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 236, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-01-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Liver Cirrhosis",
                "aff": "Asian American Liver Centre - Gleneagles Hospital (Annexe Block), Singapore, Singapore",
                "url": "https://ClinicalTrials.gov/show/NCT03626090",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 209, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-01-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103,
                    1
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Liver Cirrhosis",
                "aff": "Parkway Cancer Centre - Gleneagles Hospital, Singapore, Singapore",
                "url": "https://ClinicalTrials.gov/show/NCT03626090",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 209, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-01-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103,
                    1
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Liver Cirrhosis",
                "aff": "Desmond Wai Liver & Gastrointestinal Disease Centre - Mount Elizabeth Novena Specialist Centre, Singapore, Singapore",
                "url": "https://ClinicalTrials.gov/show/NCT03626090",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 209, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-01-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103,
                    1
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation",
                "aff": "Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05131412",
                "enrolled": 107,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 206, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-10-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis",
                "aff": "Accurate Clinical Research, Pasadena, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03691909",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 204, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-08-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.",
                "aff": "Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01844661",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 238, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-05-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Linagliptin and Mesenchymal Stem Cells: A Pilot Study",
                "aff": "University of Nevada School of Medicine, Reno, Nevada, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02442817",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 239, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -119,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy",
                "aff": "Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Curitiba, Paran\u00e1, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01913886",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 214, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -40,
                    -20
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting",
                "aff": "Pontificia Universidade Cat\u00f3lica do Rio Grande do Sul, Porto Alegre, RS, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04998058",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 240, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -51,
                    -30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia",
                "aff": "Hospital Puerta de Hierro, Majadahonda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01909154",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 217, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-07-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula",
                "aff": "Seoul Natinoal Univetsity Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04612465",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 237, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-01-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04612465",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 237, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-01-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04612465",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 237, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-01-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Exploratory Efficacy Study of NEUROSTEM\u00ae Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02054208",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 227, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2014-02-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mobilization of Mesenchymal Stem Cells During Liver Transplantation",
                "aff": "University Hospital, Newark, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02557724",
                "enrolled": 35,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 227, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial",
                "aff": "Seoul national University Hospital, Seoul, Jongno-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04339504",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 206, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-04-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study)",
                "aff": "Hospital de Elche, Elche, Alicante, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05210309",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 222, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study)",
                "aff": "HOSPITAL Meixoeiro Vigo, Vigo, Pontevedra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05210309",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 222, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study)",
                "aff": "Hospital Vall D\u00b4Hebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05210309",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 222, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study)",
                "aff": "Hospital La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05210309",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 222, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease",
                "aff": "Shaanxi Provincial People's Hospital, Xi Ail, Shaanxi, China",
                "url": "https://ClinicalTrials.gov/show/NCT02445547",
                "enrolled": 82,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 217, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2012-05-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    109,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration",
                "aff": "The Emory Clinic, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03014037",
                "enrolled": 35,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 227, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis",
                "aff": "Institute of Bio-Stem Cell Rehabilitation, Kharkov, Ukraine",
                "url": "https://ClinicalTrials.gov/show/NCT05080465",
                "enrolled": 700,
                "radius": 36,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 231, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9964,
                "paneLabel": "pane9964",
                "start": "2018-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    36,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis",
                "aff": "Haikou People's Hospital, Haikou, China",
                "url": "https://ClinicalTrials.gov/show/NCT05106972",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 221, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    20
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction",
                "aff": "Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04972890",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 245, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-09-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells",
                "aff": "AOU Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT05167188",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 241, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-09-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Articular Cartilage Resurfacing With Mesenchymal Stem Cells In Osteoarthritis Of Knee Joint",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01207661",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 199, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2009-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial",
                "aff": "Direct Biologics, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05125562",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 220, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2022-11-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee",
                "aff": "McConnell Spine, Sport, and Joint Physicians, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02958267",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 201, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-10-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Mesenchymal Stem Cell Derived EVs for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial",
                "aff": "PRX Research, Mesquite, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05354141",
                "enrolled": 400,
                "radius": 30,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 223, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9970,
                "paneLabel": "pane9970",
                "start": "2022-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy",
                "aff": "The Central Hospital of Wuhan, Wuhan, Hubei, China",
                "url": "https://ClinicalTrials.gov/show/NCT05507697",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 216, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-05-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    114,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis",
                "aff": "Department of Urology, Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04610359",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 245, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2020-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury",
                "aff": "Hospital S\u00e3o Rafael, Salvador, Bahia, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01325103",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 215, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-03-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -38,
                    -12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells",
                "aff": "Traumatology department. Complejo Hospitalario de Salamanca, Salamanca, Castilla y Le\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02123368",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 221, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-04-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells",
                "aff": "Orthopaedic and traumatology department. Cl\u00ednica Universidad de Navarra, Pamplona, Navarra, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02123368",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 221, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-04-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Miami VA Healthcare System, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 229, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2020-07-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "University of Maryland Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 229, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2020-07-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)",
                "aff": "Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04629105",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 229, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2020-07-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture",
                "aff": "CHA University, CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05018637",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 205, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of California, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Clinical Research of West Florida, Clearwater, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Shafran Gastroenterology Center, Winter Park, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of Maryland, Baltimore, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Chevy Chase Clinical Research, Chevy Chase, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Saint Louis Center for Clinical Research, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "St. Louis Center for Clinical Studies, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Dartmouth HItchcock Medical Center, Lebanon, New Hampshire, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Weill Cornell Medical College, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Gastroenterology Center of the Midsouth, PC, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Vanderbilt University Medical Center, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "McGuire Research Institute, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Royal Melbourne Hospital, Melbourne, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "University of Otago, Christchurch, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    172,
                    -43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of PROCHYMAL\u00ae for Treatment-refractory Moderate-to-severe Crohn's Disease",
                "aff": "Waikato Hospital, Hamilton, New Zealand",
                "url": "https://ClinicalTrials.gov/show/NCT01233960",
                "enrolled": 73,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 212, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    175,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Brain Matters Research, Delray Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 226, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 226, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",
                "aff": "Miami Jewish Health, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02600130",
                "enrolled": 33,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 226, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease",
                "aff": "Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02474342",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 211, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-07-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "Geauga Regional Hospital, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "Lake/University Ireland Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "University Suburban Health Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "UHHS Chagrin Highlands Medical Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "Southwest General Health Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "UHHS Westlake Medical Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant",
                "aff": "Mercy Cancer Center at Mercy Medical Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00361049",
                "enrolled": 49,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Non Union of Long Bone Fractures by Autologous Mesenchymal Stem Cell",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01206179",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 233, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2009-08-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mercy Gilbert Medical Center / Catholic Health Care West, Gilbert, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Arizona, Tucson, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -110,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UC Davis Medical Center, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of California - San Diego (UCSD), San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Mount Sinai Medical Center, Miami Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Miami, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Care Group, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Cotton-O'Neil Clinical Research Center, Topeka, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Maryland Hospital, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Tufts Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Baystate Medical Center, Springfield, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -72,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMass Memorial Medical Center, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "William Beaumont Hospital, Royal Oak, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Michigan Cardiovascular Institute, Saginaw, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Minneapolis Heart Institute, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University at Buffalo - Buffalo General Hospital, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Stony Brook University Medical Center, Stony Brook, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Lindner Research Center, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Ohio State University Medical Center, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Penn State University - Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Drexel University College of Medicine, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Allegheny General Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "The Stern Cardiovascular Center, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Austin Heart P.A., Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Texas Health Science Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "Fletcher Allen Health Care, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "University of Wisconsin School of Medicine, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Prochymal\u00ae (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)",
                "aff": "McGill University Health Centre, Montreal, Quebec, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00877903",
                "enrolled": 220,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 221, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2009-03-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation",
                "aff": "Ankara University Biotechnology Institute, Ankara, T\u00fcrkiye, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04877067",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 225, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation",
                "aff": "Umut Arslan, Ankara, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04877067",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 225, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    32,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease",
                "aff": "Nanjing Medical University, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT03460795",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 245, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-06-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer",
                "aff": "University of Colorado Cancer Center, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02331134",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 202, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2015-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01454336",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 237, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2010-09-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "University of Southern California, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "Orthopedic Center of Vero Beach, Vero Beach, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "Midwest Orthopaedics at Rush, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "Ortholndy, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "Greater Chesapeake Associates, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "TRIA Orthopaedic Center, Bloomington, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "Triangle Orthopaedics Associates, P.A., Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "Unlimited Research, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00225095",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 213, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2005-08-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring",
                "aff": "Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT03592849",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 239, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2018-08-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling",
                "aff": "China Medical Universty Hospital, Taichung, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT01323894",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 241, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2011-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    24
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)",
                "aff": "Kit Bartalos, Liberty, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05387278",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 228, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-05-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Chondrochymal\u00ae for Subjects With Knee Osteoarthritis (Knee OA)",
                "aff": "Taipei Veterans General Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT05027581",
                "enrolled": 70,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 218, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2021-08-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effect of NF-\u043aB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 Diabetes",
                "aff": "Mattabhorn Phornputkul, Chiang Mai, Thailand",
                "url": "https://ClinicalTrials.gov/show/NCT02286128",
                "enrolled": 75,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 229, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2014-10-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    98,
                    18
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Bone Marrow Derived Stem Cell Transplantation in T2DM",
                "aff": "Postgraduate Institute of Medical Education and Research, Chandigarh, UT, India",
                "url": "https://ClinicalTrials.gov/show/NCT01759823",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 231, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2012-01-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    79,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM\u00ae Phase II (MP-CR-012) Clinical Trial",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04003857",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 207, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2019-07-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM\u00ae Phase II (MP-CR-012) Clinical Trial",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04003857",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 207, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2019-07-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis",
                "aff": "University Hospital Reina Sofia, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01745783",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 245, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis",
                "aff": "University Regional Hospital Carlos Haya, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01745783",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 245, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis",
                "aff": "University Hospital Virgen Macarena, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01745783",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 245, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-11-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke",
                "aff": "Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam",
                "url": "https://ClinicalTrials.gov/show/NCT05292625",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 233, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-07-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    105,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis",
                "aff": "TriWest Research Associates, El Cajon, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04368806",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 205, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -116,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis",
                "aff": "BioSolutions Clinical Research Center, La Mesa, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04368806",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 205, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis",
                "aff": "Source Healthcare, Santa Monica, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04368806",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 205, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis",
                "aff": "International Spine Pain, and Performance Center, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04368806",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 205, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis",
                "aff": "Rothman Orthopaedic Institute, Egg Harbor Township, New Jersey, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04368806",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 205, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -74,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis",
                "aff": "Hospital for Special Surgery, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04368806",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 205, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-05-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients",
                "aff": "Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT04275024",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 210, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2020-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM\u00ae Phase-II Clinical Trial",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01897987",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 203, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-07-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM\u00ae Phase-II Clinical Trial",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01897987",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(244, 203, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-07-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety Evaluation of Pneumostem\u00ae Versus a Control Group for Treatment of BPD in Premature Infants",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01828957",
                "enrolled": 69,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 214, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2013-04-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety Evaluation of Pneumostem\u00ae Versus a Control Group for Treatment of BPD in Premature Infants",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01828957",
                "enrolled": 69,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 214, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2013-04-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05116540",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 208, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-10-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Stem Cell Therapy in Patients With Autism",
                "aff": "Shandong Jiaotong Hospital, Jinan, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT01343511",
                "enrolled": 37,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 203, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2009-04-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    117,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of hAMSCs for Woman With DOR",
                "aff": "Clinical Center of Reproductive Medicine at the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT04706312",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-01-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Frailty Syndrome",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04914403",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 231, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2021-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04739930",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 221, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2018-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis",
                "aff": "Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04037345",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 213, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04097652",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 244, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-11-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02195323",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 246, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2014-07-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients",
                "aff": "Bundang CHA Medical Center, Seongnam, Kyunggido, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04657315",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 223, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-06-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04206007",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 205, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)",
                "aff": "Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare., New Taipei City, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04347967",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 218, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-04-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM\u00ae in Patients Who Completed PNEUMOSTEM\u00ae Phase-I Study",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02023788",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 230, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2014-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).",
                "aff": "Taipei Medical University Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT04893174",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 221, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2022-05-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)",
                "aff": "University Hospital Tuebingen, Tuebingen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT04377334",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 209, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-05-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Knee Osteoarthritis",
                "aff": "Bluetail Medical Group, Chesterfield, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05288725",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 212, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2022-03-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Knee Osteoarthritis",
                "aff": "Scarpone Sports Regenerative, Steubenville, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05288725",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 212, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2022-03-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell Therapy for Knee Osteoarthritis",
                "aff": "Albano Clinic, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05288725",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 212, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2022-03-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip",
                "aff": "Department of Orthopaedic Surgery, H\u00f4pital Henri Mondor, Cr\u00e9teil, France",
                "url": "https://ClinicalTrials.gov/show/NCT02065167",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 210, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip",
                "aff": "Department of Orthopaedic Surgery, CHU Tours, Tours, France",
                "url": "https://ClinicalTrials.gov/show/NCT02065167",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 210, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip",
                "aff": "University Children's Hospital, T\u00fcbingen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT02065167",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 210, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip",
                "aff": "Department of Orthopaedic Trauma, University of Ulm, Ulm, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT02065167",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 210, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip",
                "aff": "Istituto Ortopedico Rizzoli, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02065167",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 210, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip",
                "aff": "Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda \"A\", Hospital La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02065167",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 210, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.",
                "aff": "PT Prodia StemCell Indonesia, Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05279768",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 214, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)",
                "aff": "Inha University Hospital, In Cheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01318330",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 231, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01318330",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 231, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)",
                "aff": "Seoul St. Mary's Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01318330",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 231, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01318330",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 231, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-03-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease",
                "aff": "Kansas University Cancer Center, Kansas City, Kansas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03158896",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 206, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-07-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia",
                "aff": "Pusan National University Hospital, Pusan, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01663376",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 223, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2009-01-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    128,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02755376",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 210, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)",
                "aff": "Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04928287",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-06-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of Safety and Efficacy of Pneumostem\u00ae in Premature Infants With Bronchopulmonary Dysplasia",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01632475",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 240, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-07-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones",
                "aff": "Christian Medical College, Vellore, Tamil Nadu, India",
                "url": "https://ClinicalTrials.gov/show/NCT04623606",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 213, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-05-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    79,
                    12
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy",
                "aff": "Institute of Bio-Stem Cell Rehabilitation, Kharkov, Ukraine",
                "url": "https://ClinicalTrials.gov/show/NCT04642911",
                "enrolled": 91,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 232, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2020-09-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    36,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries",
                "aff": "Hospital Puerta de Hierro, Majadahonda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02570932",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 213, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.",
                "aff": "Azidus Brasil Pesquisa Cient\u00edfica e Desenvolvimento Ltda., Valinhos, S\u00e3o Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT04219241",
                "enrolled": 35,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 247, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-02-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Boost Brittle Bones Before Birth",
                "aff": "Karolinska University Hospital, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT03706482",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 235, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-09-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    18,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "David Geffen School of Medicine at UCLA, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 223, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 223, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "American Health Research, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 223, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Upstate Pharmaceutical Research, Greenville, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 223, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Spartanburg Medical Research, Spartanburg, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 223, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "PROCHYMAL\u2122 (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",
                "aff": "Vermont Lung Center, University of Vermont, Burlington, Vermont, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00683722",
                "enrolled": 62,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 223, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-03-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05095532",
                "enrolled": 42,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 213, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Prochymal\u00ae for the Salvage of Treatment-Refractory Acute GVHD Patients",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00284986",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 202, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2005-10-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy",
                "aff": "Institute of Bio-Stem Cell Rehabilitation, Kharkov, Ukraine",
                "url": "https://ClinicalTrials.gov/show/NCT04675970",
                "enrolled": 86,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 211, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2020-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    36,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC and BMMNC in Type 2 Diabetes Mellitus",
                "aff": "Fuzhou General Hospital, Xiamen Univ, Fuzhou, Fujian, China",
                "url": "https://ClinicalTrials.gov/show/NCT01719640",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 245, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2011-10-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    119,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease",
                "aff": "Azidus Brasil Pesquisa Cient\u00edfica e Desenvolvimento Ltda., Valinhos, S\u00e3o Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT02728115",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 246, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-09-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis",
                "aff": "Beijing 302 Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT01220492",
                "enrolled": 266,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 233, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2009-09-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effects of Muscle Energy Technique in Knee Osteoarthritis Patients",
                "aff": "Institute of Regenerative medicine, Islamabad, Pakistan",
                "url": "https://ClinicalTrials.gov/show/NCT05349565",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 200, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2022-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells",
                "aff": "Laboratory for Cell Research and Application, Medical University of Warsaw, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03887208",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 232, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    20,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells",
                "aff": "Melitus sp. z o.o., Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03887208",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 232, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells",
                "aff": "Timeless Chirurgia Plastyczna Sp. z o. o., Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03887208",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 232, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "Helen Keller Hospital, Sheffield, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 206, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "St. Joseph Hospital Heritage, Fullerton, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 206, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "Donald Guthrie Foundation/ Robert Packer Hospital, Sayre, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 206, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "Covenant Health, Lubbock, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 206, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -101,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS",
                "aff": "PRX Research, Mesquite, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04493242",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 206, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells",
                "aff": "Yantai Yuhuangding Hospital, Yantai, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05155657",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 204, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-06-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Cordstem-ST in Patients With Cerebral Infarction",
                "aff": "CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02378974",
                "enrolled": 19,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 220, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China",
                "aff": "General Hospital of Chinese People's Armed Police Forces, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT01873547",
                "enrolled": 300,
                "radius": 27,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 212, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9973,
                "paneLabel": "pane9973",
                "start": "2012-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease",
                "aff": "ATP Clinical Research, Costa Mesa, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03117738",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 223, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-05-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease",
                "aff": "Syrentis Clinical Research, Santa Ana, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03117738",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 223, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-05-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease",
                "aff": "Valden Medical, Honolulu, Hawaii, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03117738",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 223, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-05-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -157,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Orthopedic Pain Specialists, Santa Monica, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02674399",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 229, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Walnut Creek, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02674399",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 229, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-02-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting",
                "aff": "Syddansk Universitet SDU (University Hospital of Southern Denmark), Odense, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT04297813",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 207, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting",
                "aff": "Assistance Publique - H\u00f4pitaux De Paris, Cr\u00e9teil, France",
                "url": "https://ClinicalTrials.gov/show/NCT04297813",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 207, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting",
                "aff": "CHU Nantes, Centre de Soins Dentaires, Nantes, France",
                "url": "https://ClinicalTrials.gov/show/NCT04297813",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 207, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting",
                "aff": "University of Bergen, Institute of Clonical Dentistry, Bergen, Hordaland, Norway",
                "url": "https://ClinicalTrials.gov/show/NCT04297813",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 207, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    60
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting",
                "aff": "Universidad Complutense De Madrid, Madrid, Calle Fernando De Castro Rodriguez,, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04297813",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 207, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting",
                "aff": "Universitat Internacional De Catalunya, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04297813",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 207, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Study of Allergic Rhinitis Therapy by Stem Cells",
                "aff": "Yantai Yuhuangding Hospital, Yantai, Shandong, China",
                "url": "https://ClinicalTrials.gov/show/NCT05151133",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 243, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2022-06-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD)",
                "aff": "Jorge L. Alio, Alicante, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05279157",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 248, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions",
                "aff": "Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04684602",
                "enrolled": 5000,
                "radius": 80,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 206, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9920,
                "paneLabel": "pane9920",
                "start": "2020-07-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Effects of ASC Secretome on Human Osteochondral Explants",
                "aff": "IRCCS Istituto Ortopedico Galeazzi, Milano, MI, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT04223622",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 244, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-04-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs).",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT04288934",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 208, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-02-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Andrews Institute, Gulf Breeze, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 214, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9969,
                "paneLabel": "pane9969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "The Emory Clinic, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 214, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9969,
                "paneLabel": "pane9969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 214, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9969,
                "paneLabel": "pane9969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Fargo, North Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 214, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9969,
                "paneLabel": "pane9969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)",
                "aff": "Sanford Health, Sioux Falls, South Dakota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03818737",
                "enrolled": 480,
                "radius": 31,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 214, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9969,
                "paneLabel": "pane9969",
                "start": "2019-03-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs Therapy for Cerebral Palsy",
                "aff": "Aljazeera( Al Gazeera) hospital, Giza, Egypt",
                "url": "https://ClinicalTrials.gov/show/NCT04653077",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 241, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-11-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    31,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis",
                "aff": "Centro Medico Teknon-ITRT, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01227694",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 223, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-09-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administrations of NurOwn\u00ae in ALS Patients",
                "aff": "University of California Irvine Alpha Stem Cell Clinic, Irvine, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03280056",
                "enrolled": 263,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 212, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2017-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administrations of NurOwn\u00ae in ALS Patients",
                "aff": "Cedars-Sinai Medical Center, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03280056",
                "enrolled": 263,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 212, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2017-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administrations of NurOwn\u00ae in ALS Patients",
                "aff": "California Pacific Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03280056",
                "enrolled": 263,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 212, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2017-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administrations of NurOwn\u00ae in ALS Patients",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03280056",
                "enrolled": 263,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 212, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2017-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administrations of NurOwn\u00ae in ALS Patients",
                "aff": "University of Massachusetts Medical School, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03280056",
                "enrolled": 263,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 212, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2017-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of Repeated Administrations of NurOwn\u00ae in ALS Patients",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03280056",
                "enrolled": 263,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 212, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2017-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD",
                "aff": "Campus Bio-Medico University of Rome, Roma, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT04759105",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 202, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2020-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease",
                "aff": "Erciyes University, Kayseri, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT05305833",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 215, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)",
                "aff": "The John Paul II Hospital, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03404063",
                "enrolled": 105,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 203, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2017-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)",
                "aff": "Central Clinical Hospital of the MSWiA in Warsaw, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03404063",
                "enrolled": 105,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 203, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2017-09-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Microneedle Versus Fractional CO\u2082 Laser for Skin Aging Treatment With Stem Cell Secretome in Indonesian Adult Women",
                "aff": "Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05508191",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 227, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2022-01-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD",
                "aff": "Campus Bio-Medico University of Rome, Roma, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT05066334",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 240, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-03-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT04034615",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 217, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2021-05-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars",
                "aff": "Maternal and Child Health Hospital of Foshan, Foshan, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT02772289",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 210, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Early Rheumatoid Arthritis",
                "aff": "UH Hospitals Cleveland, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03186417",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 244, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cells in Early Rheumatoid Arthritis",
                "aff": "MetroHealth Medical Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03186417",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 244, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stem Cell and Islet Co-transplantation",
                "aff": "GI Surgery, Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02384018",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2014-03-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation",
                "aff": "St. Francis Medical Center, Lynwood, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04397796",
                "enrolled": 45,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 222, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-05-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients",
                "aff": "Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology, Minsk, Belarus",
                "url": "https://ClinicalTrials.gov/show/NCT04281797",
                "enrolled": 90,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 207, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    27,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dysfunctions of Human Muscle Stem Cells in Sepsis",
                "aff": "Hopital Henri Mondor, Service de R\u00e9animation chirurgicale polyvalente, Cr\u00e9teil, France",
                "url": "https://ClinicalTrials.gov/show/NCT02789995",
                "enrolled": 93,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 239, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-06-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dysfunctions of Human Muscle Stem Cells in Sepsis",
                "aff": "H\u00f4pital Piti\u00e9 Salp\u00e9tri\u00e8re, Salle de surveillance post-interventionnelle, Accueil des Polytraumatis\u00e9s, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02789995",
                "enrolled": 93,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 239, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-06-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dysfunctions of Human Muscle Stem Cells in Sepsis",
                "aff": "H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Anesth\u00e9sie et R\u00e9animation, Institut de Cardiologie, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02789995",
                "enrolled": 93,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 239, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-06-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dysfunctions of Human Muscle Stem Cells in Sepsis",
                "aff": "H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Service de Chirurgie G\u00e9n\u00e9rale, Visc\u00e9rale et Endocrinienne, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02789995",
                "enrolled": 93,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 239, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-06-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dysfunctions of Human Muscle Stem Cells in Sepsis",
                "aff": "H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Service de Chirurgie H\u00e9patobiliaire et de Transplantation H\u00e9patique, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02789995",
                "enrolled": 93,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 239, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-06-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dysfunctions of Human Muscle Stem Cells in Sepsis",
                "aff": "H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Service de r\u00e9animation chirurgicale polyvalente, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02789995",
                "enrolled": 93,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 239, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-06-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dysfunctions of Human Muscle Stem Cells in Sepsis",
                "aff": "H\u00f4pital Saint-Antoine, D\u00e9partement d'Anesth\u00e9sie-r\u00e9animation, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02789995",
                "enrolled": 93,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 239, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-06-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT",
                "aff": "Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04738981",
                "enrolled": 130,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 229, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2021-02-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Biochemical Correction of Severe EB by Allo HSCT and \"Off-the-shelf\" MSCs",
                "aff": "University of Minnesota Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01033552",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 246, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2010-11-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability Study of MSC Exosome Ointment",
                "aff": "National University Hospital, Singapore, Singapore",
                "url": "https://ClinicalTrials.gov/show/NCT05523011",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 200, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-03-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    103,
                    1
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)",
                "aff": "Beijing Tiantan Hospital, Capital Medical University, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT04590118",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 227, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis",
                "aff": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",
                "url": "https://ClinicalTrials.gov/show/NCT05280002",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 202, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    90,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Chungbuk National University Hospital, Cheongju-si, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Yeungnam University Hospital, Daegu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Chonbuk National University Hospital, Jeonju, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Gyeongsang National University Hospital, Jinju-si, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Kyunghee University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Yonsei University Health System, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Soonchunhyang University Hospital Seoul, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "KyungHee University Gangdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis",
                "aff": "Chunang University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03990805",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 213, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2019-06-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Use of Stem Cells for the Treatment of Covid-19",
                "aff": "Istinye University, Istanbul, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04392778",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 222, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Use of Stem Cells for the Treatment of Covid-19",
                "aff": "SB\u00dc Dr. Sadi Konuk E\u011fitim ve Ara\u015ft\u0131rma Hastanesi, Istanbul, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04392778",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 222, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease",
                "aff": "Azidus Brasil Pesquisa Cient\u00edfica e Desenvolvimento Ltda., Valinhos, S\u00e3o Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT03252535",
                "enrolled": 35,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 243, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury",
                "aff": "Anupam Hospital, Rudrapur, Uttaranchal, India",
                "url": "https://ClinicalTrials.gov/show/NCT02742857",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 232, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    79,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19",
                "aff": "Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04390139",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 226, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19",
                "aff": "M\u00fatua de Terrassa, Terrassa, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04390139",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 226, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19",
                "aff": "Hospital del Mar, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04390139",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 226, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19",
                "aff": "Hospital Vall d'Hebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04390139",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 226, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19",
                "aff": "Hospital Cl\u00ednic de Barcelona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04390139",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 226, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-05-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia",
                "aff": "Isar Medizin Zentrum, Munich, Bavaria, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01351610",
                "enrolled": 25,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 220, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2011-05-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence",
                "aff": "Maternity hospital, Ain Shams University, Cairo, Egypt",
                "url": "https://ClinicalTrials.gov/show/NCT02334878",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 218, 218)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    31,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.",
                "aff": "KyungHee University Gangdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03000712",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 219, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-10-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral",
                "aff": "Hospital Regional Universitario Reina Sof\u00eda, Cordoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02290886",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 222, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-10-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral",
                "aff": "Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02290886",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 222, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-10-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral",
                "aff": "Hospital Universitario Virgen Macarena, Servicio de Neurolog\u00eda, Seville, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02290886",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 222, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-10-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral",
                "aff": "Hospital Universitario Virgen del Roc\u00edo, Seville, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02290886",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 222, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2014-10-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Complexo Hospitalario Universitario A Coru\u00f1a, A Coru\u00f1a, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Hospital Universitari Vall d'Hebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Hospital Universitario Virgen de las Nieves, Granada, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Hospital Universitario 12 de Octubre, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Complejo Hospitalario de Toledo (HNP y VS), Toledo, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Hospital Universitari La Fe, Valencia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Hospital Cl\u00ednico Universitario Lozano Blesa, Zaragoza, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury",
                "aff": "Hospital Universitario Miguel Servet, Zaragoza, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02917291",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 235, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan",
                "aff": "Pak Emirates Military Hospital, Rawalpindi, Punjab, Pakistan",
                "url": "https://ClinicalTrials.gov/show/NCT04492501",
                "enrolled": 600,
                "radius": 34,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 227, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9966,
                "paneLabel": "pane9966",
                "start": "2020-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    73,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Gachon University Gil Hospital, Incheon, Gyunggido, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Seoul Veterans Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Korea University Guro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury",
                "aff": "Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01041001",
                "enrolled": 104,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 234, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2009-11-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC Intratissular Injection in Crohn Disease Patients",
                "aff": "CHU de Li\u00e8ge, Li\u00e8ge, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT03901235",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 206, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2018-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19",
                "aff": "Mission Community Hospital, Panorama City, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04798716",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 228, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2023-03-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Biosolutions Clinical Research Center, La Mesa, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "010 : Triwest Research Associates : USA : Levy, Louis J. Levy, Louis J. Principal Investigator llevy@triwestresearch.com 619-589-6888 San Diego, CA, 92108, United States, San Diego, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Denver Back Pain Specialists, LLC, Greenwood Village, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Georgetown Washington University, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Pain Relief Centers, Saint Petersburg, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Tampa Pain Relief Center, Tampa, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Long Island Spine Rehabilitation Medicine, East Meadow, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Mount Sinai, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "The Center of Clinical Research, LLC, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Coastal Carolina Research Center, North Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Premier Pain Centers, Richardson, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Precision Spine Care, Tyler, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)",
                "aff": "Virginia iSpine Physicians, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04042844",
                "enrolled": 99,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 247, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2022-06-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stromal Cells for Multiple Sclerosis",
                "aff": "Hospital Vall Hebron, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02495766",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 206, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2015-05-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effects of Antibiotic Combinations on Stem Cells",
                "aff": "Eski\u015fehir Osmangazi University, Eski\u015fehir, Turkey",
                "url": "https://ClinicalTrials.gov/show/NCT04713436",
                "enrolled": 3,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 220, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2014-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    34,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)",
                "aff": "Stem Cell laboratory, Jinnah Burn & Reconstructive Surgery Centre, Lahore, Punjab, Pakistan",
                "url": "https://ClinicalTrials.gov/show/NCT04763369",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 236, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-02-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    74,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "ADMSCs for the Treatment of Systemic Sclerosis",
                "aff": "Seoul St. Mary's hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02975960",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 246, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2016-09-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01207193",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 242, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2009-08-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "UC-MSCs Gel Treatment Difficult Healing of Skin Ulcers",
                "aff": "Chinese PLA General Hospital, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02685722",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 247, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2012-02-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "SVF (Adipose Tissue Derived MSC) Based Therapy for CKD.",
                "aff": "Bangladesh Laser And Cell Surgery Institute And Hospital, Dhaka, Bangladesh",
                "url": "https://ClinicalTrials.gov/show/NCT03939741",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 232, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    90,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pilot Synovial Fluid Molecular/Stem Cell Response to PRP in Knee Osteoarthritis: Clinical & Imaging Outcome Correlation",
                "aff": "Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02468492",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 212, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Senescence in Chronic Kidney Disease",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02848131",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 248, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2016-07-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF)",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02801890",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 201, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-06-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients",
                "aff": "RSPAD Gatot Soebroto, Jakarta, DKI Jakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05216562",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 211, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    106,
                    -6
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients",
                "aff": "RSUP Dr. M. Jamil, Padang, West Sumatra, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05216562",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 211, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    100,
                    0
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients",
                "aff": "RSUP Dr. Sardjito, Yogyakarta, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT05216562",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 211, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    110,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Distraction Osteogenesis in Limb-length Discrepancy With Mesenchymal Cell Transplantation",
                "aff": "Royan Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01210950",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 231, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2009-08-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair",
                "aff": "Chapel Allerton Orthopaedic Centre, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT02696876",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 201, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Oxidative Stress as an Acute Exercise-induced Mechanism of Stem and Progenitor Cell Mobilization",
                "aff": "Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich, Z\u00fcrich, Zurich, Switzerland",
                "url": "https://ClinicalTrials.gov/show/NCT03747913",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 246, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2019-05-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy",
                "aff": "Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03265444",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 229, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-04-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial",
                "aff": "Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04427930",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 210, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2020-04-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial",
                "aff": "KyungHee University Gangdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04427930",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 210, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2020-04-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04427930",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 210, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2020-04-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial",
                "aff": "The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04427930",
                "enrolled": 260,
                "radius": 26,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 210, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9974,
                "paneLabel": "pane9974",
                "start": "2020-04-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)",
                "aff": "Rigshospitalet University Hospital Copenhagen, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT01449032",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 205, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2010-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells",
                "aff": "Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02313415",
                "enrolled": 26,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 216, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2014-10-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "UC-MSC Transplantation for Left Ventricular Dysfunction After AMI",
                "aff": "Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT03902067",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 230, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2022-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound",
                "aff": "Chinese PLA General Hospital, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02669199",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 232, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2012-02-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Stem Cells for the Treatment of No Option Critical Limb Ischemia",
                "aff": "Galway University Hospital, Galway City, Galway, Ireland",
                "url": "https://ClinicalTrials.gov/show/NCT03455335",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 231, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -9,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration",
                "aff": "Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China",
                "url": "https://ClinicalTrials.gov/show/NCT04074408",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 246, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-05-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    120,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Collecting Bone Graft During Spinal Decompression and Posterolateral Lumbar Fusion to Better Define Bone Making Cells",
                "aff": "University of Utah Orthopaedic Center, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01409954",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 216, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2011-09-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis",
                "aff": "Department of Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT01709656",
                "enrolled": 120,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 211, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease",
                "aff": "ASAN Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01309061",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 237, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2008-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC",
                "aff": "University of Utah, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03838250",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 216, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-06-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma",
                "aff": "M D Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03896568",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 221, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-02-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Plan of Ischemic Stroke",
                "aff": "Peking University Third Hospital, Beijin, China",
                "url": "https://ClinicalTrials.gov/show/NCT04953663",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 237, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    112,
                    21
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF",
                "aff": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China",
                "url": "https://ClinicalTrials.gov/show/NCT02644447",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 206, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-11-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    118,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Nepean Hospital, Kingswood, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    150,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "St George Hospital, Kogarah, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Westmead Hospital, Westmead, New South Wales, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    150,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Footscray Hospital, Footscray, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause",
                "aff": "Sunshine Hospital, Saint Albans, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT04537351",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-08-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trials of Regeneration for Periodontal Tissue",
                "aff": "\uff29\uff4estitute of Biomedical Research and Innovation, Kobe, Hyogo Pref., Japan",
                "url": "https://ClinicalTrials.gov/show/NCT00221130",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 241, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2004-08-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    134,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells",
                "aff": "Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Arag\u00f3n, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01803347",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 230, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2013-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells",
                "aff": "Hospital Cl\u00ednico Universitario, Salamanca, Castilla-Leon, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01803347",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 230, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2013-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells",
                "aff": "Hospital General Universitario, Valencia, Comunidad Valenciana, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01803347",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 230, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2013-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells",
                "aff": "Hospital Universitario La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01803347",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 230, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2013-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells",
                "aff": "Cl\u00ednica Universitaria de Navarra, Pamplona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01803347",
                "enrolled": 80,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 230, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2013-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02017912",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 244, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2014-11-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS",
                "aff": "UMass Medical School, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02017912",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 244, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2014-11-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02017912",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 244, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2014-11-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation",
                "aff": "The Third Affiliated Hospital Of Sun Yat-sen University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT00956891",
                "enrolled": 158,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 249, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2005-05-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke",
                "aff": "Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China",
                "url": "https://ClinicalTrials.gov/show/NCT01468064",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 220, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2011-10-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    113,
                    23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma",
                "aff": "ICO Hospitalet, Hospitalet de Llobregat, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05047276",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 236, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction",
                "aff": "VA Healthcare System, San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03678467",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 248, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2021-03-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction",
                "aff": "Cleveland Clinic, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03678467",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 248, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2021-03-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction",
                "aff": "UT Health San Antonio, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03678467",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(210, 248, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2021-03-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Venenzentrum der Dermatologischen und Gef\u00e4\u00dfchirurgischen Kliniken, Kliniken der Ruhr-Universit\u00e4t Bochum im St. Maria Hilf Krankenhaus, Bochum, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    7,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Universit\u00e4tsklinikum Erlangen, Hautklinik, Erlangen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinik und Poliklinik f\u00fcr Hautkrankheiten, Universit\u00e4tsmedizin Greifswald, Greifswald, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinische Forschung Hamburg GmbH, Dermatologie / Allergologie, Hamburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "pro scientia med im Mare Klinikum; Department Klinische Forschung und Entwicklung, Kiel, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Universit\u00e4tsklinikum M\u00fcnster, Klinik f\u00fcr Hautkrankheiten, Allgemeine Dermatologie und Venerologie, M\u00fcnster, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinische Forschung Schwerin GmbH, Schwerin, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Universit\u00e4tsklinikum Ulm, Klinik f\u00fcr Dermatologie und Allergologie, Ulm, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of CVU",
                "aff": "Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03257098",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 237, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2017-10-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Universit\u00e4tsmedizin Greifswald; Klinik und Poliklinik f\u00fcr Hautkrankheiten, Greifswald, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 214, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "St. Josefskrankenhaus Heidelberg GmbH; Klinische Studienabteilung, Heidelberg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 214, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Diabetologikum Raab, Privat\u00e4rztliche Facharztpraxis, Kassel, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 214, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "pro scientia med im Mare Klinikum, Department Klinische Forschung und Entwicklung, Kronshagen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 214, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Studienambulanz Leipzig, medamed GmbH, Leipzig, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 214, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Diabetologikum Ludwigshafen, Gemeinschaftspraxis, Ludwigshafen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 214, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    49
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic ABCB5-positive Stem Cells for Treatment of DFU \"Malum Perforans\"",
                "aff": "Klinik und Poliklinik f\u00fcr Dermatologie, Venerologie und Allergologie, Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT03267784",
                "enrolled": 23,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 214, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "The John Paul II Hospital, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 231, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "The University Hospital in Cracow, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 231, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "Instytut Kardiologii im. Prymasa Tysi\u0105clecia Stefana Kardyna\u0142a Wyszy\u0144skiego, Katowice, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 231, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice, Katowice, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 231, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)",
                "aff": "Central Clinical Hospital of the MSWiA in Warsaw, Warsaw, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03418233",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 231, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2018-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    21,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)",
                "aff": "The John Paul II Hospital, Cracovia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03423732",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 245, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2018-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)",
                "aff": "Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice, Katowice, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT03423732",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 245, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2018-04-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R\u00ae Inj.) Treatment in Patients With ALS",
                "aff": "Pusan National University Yangsan Hospital, Yangsan, Kyungsangnam-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04745299",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R\u00ae Inj.) Treatment in Patients With ALS",
                "aff": "Korea University Anam Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04745299",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R\u00ae Inj.) Treatment in Patients With ALS",
                "aff": "Hanyang university hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04745299",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R\u00ae Inj.) Treatment in Patients With ALS",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04745299",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R\u00ae Inj.) Treatment in Patients With ALS",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04745299",
                "enrolled": 115,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 203, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2021-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia",
                "aff": "Dankook University Hospital, Cheonan, Chung Nam, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03676400",
                "enrolled": 84,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 201, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2018-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intra-Osseous Co-Transplant of UCB and hMSC",
                "aff": "Case Comprehensive Cancer Center, Cleveland, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02181478",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 249, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2015-07-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Immune Modulation by Exosomes in COVID-19",
                "aff": "Ulm University Hospital, Clinic of Anesthesiology and Intensive Care Medicine, Ulm, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT05191381",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 235, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2021-11-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02582489",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 246, 241)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2017-11-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia",
                "aff": "Herz- und Diabeteszentrum Nordrhein Westfalen, Bad Oeynhausen, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01065337",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 231, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-02-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study on Shoulder Arthritis Treatment With Intra-articular Injections of Autologous Bone Marrow Aspirate.",
                "aff": "Humanitas Research Hospital, Rozzano, Milano, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT04308213",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 203, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2019-10-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Descartes-25 in Relapsed/Refractory Multiple Myeloma",
                "aff": "Center for Cancer and Blood Disorders, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05113342",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 240, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-10-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Descartes-25 in Relapsed/Refractory Multiple Myeloma",
                "aff": "Medical College of Wisconsin, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05113342",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 240, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-10-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Descartes-30 in Acute Respiratory Distress Syndrome",
                "aff": "University of Alabama at Birmingham, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04524962",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 241, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Descartes-30 in Acute Respiratory Distress Syndrome",
                "aff": "University of California-Irvine, Irvine, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04524962",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 241, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Descartes-30 in Acute Respiratory Distress Syndrome",
                "aff": "University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04524962",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 241, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -91,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Descartes-30 in Acute Respiratory Distress Syndrome",
                "aff": "University of Maryland Medical Center Medical Center, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04524962",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 241, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Descartes-30 in Acute Respiratory Distress Syndrome",
                "aff": "Brigham and Women's Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04524962",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 241, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Descartes-30 in Acute Respiratory Distress Syndrome",
                "aff": "University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04524962",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 241, 206)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-02-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject With Lupus Nephritis",
                "aff": "Hanyang university hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04522505",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 207, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-10-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
                "aff": "Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03252340",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 233, 208)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-08-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases",
                "aff": "Galen - Ortopedia Sp. Z O.O., Bieru\u0144, Silesia, Poland",
                "url": "https://ClinicalTrials.gov/show/NCT05081921",
                "enrolled": 200,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 215, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2022-01-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    19,
                    50
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis",
                "aff": "Shepherd Center, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04956744",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 228, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-07-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis",
                "aff": "UMass Memorial Medical Center, Worcester, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04956744",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 228, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-07-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis",
                "aff": "Rocky Mountain MS Clinic, Salt Lake City, Utah, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04956744",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 228, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-07-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 1 Clinical Trial of PNEUMOSTEM\u00ae Treatment in Premature Infants With Intraventricular Hemorrhage",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02274428",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 248, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2014-09-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis",
                "aff": "Asian Institute Of Gastroenterology, Hyderabad, Telangana, India",
                "url": "https://ClinicalTrials.gov/show/NCT04243681",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 230, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78,
                    17
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study of Chondrogen\u00ae Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "University of Southern California Keck School of Medicine, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00702741",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 224, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study of Chondrogen\u00ae Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "OrthoIndy, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00702741",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 224, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study of Chondrogen\u00ae Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "TRIA Orthopaedic Center, Bloomington, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00702741",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 224, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-up Study of Chondrogen\u00ae Delivered by Intra-Articular Injection Following Meniscectomy",
                "aff": "Unlimited Research, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00702741",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 224, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-06-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease",
                "aff": "Medical University of Vienna, Vienna, Austria",
                "url": "https://ClinicalTrials.gov/show/NCT05322057",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    16,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders",
                "aff": "Arnaud de villeneuve Hospital, Montpellier, Herault, France",
                "url": "https://ClinicalTrials.gov/show/NCT03855631",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 223, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2020-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers",
                "aff": "Central Adelaide Local Health Network, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT05165628",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 204, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2022-01-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis",
                "aff": "University of Virginia, Charlottesville, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04138017",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 240, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2018-09-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Kyunghee University Medical Center, Seoul, Dongdaemun-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 239, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Gangnam Severance Hospital, Seoul, Gangnam-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 239, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 239, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Korea University Guro Hospital, Seoul, Guro-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 239, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Chungnam National University Hospital, Daejeon, Jung-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 239, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM\u00ae) for Osteochondral Lesion of Talus",
                "aff": "Inha University Hospital, Incheon, Jung-gu, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04310215",
                "enrolled": 102,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 239, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2020-03-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    126,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis",
                "aff": "Hospital Cl\u00ednico Virgen de la Arrixaca, El Palmar, Murcia, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02566655",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 233, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-09-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis",
                "aff": "Seoul National University Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04976140",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 231, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis",
                "aff": "Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04976140",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 231, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis",
                "aff": "Hanyang University Seoul Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04976140",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(218, 231, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy",
                "aff": "Nagoya University Hospital, Nagoya, Aich, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT04261335",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 208, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    139,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)",
                "aff": "Houston Methodist Hospital, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04345601",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 202, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2021-02-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis",
                "aff": "General Hospital of Chinese People's Armed Police Forces, Beijing, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT01929434",
                "enrolled": 300,
                "radius": 27,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(234, 215, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9973,
                "paneLabel": "pane9973",
                "start": "2013-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Novel Therapeutic Treatment of Pyoderma Gangrenosum",
                "aff": "LSU Healthcare Network Clinic, Metairie, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05120726",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 238, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-06-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Novel Therapeutic Treatment of Pyoderma Gangrenosum",
                "aff": "University Medical Center, New Orleans, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05120726",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 238, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-06-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Novel Therapeutic Treatment of Pyoderma Gangrenosum",
                "aff": "Ochsner Baptist Medical Center, New Orleans, Louisiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05120726",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 238, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-06-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA)",
                "aff": "Anupam Hospital, Rudrapur, Uttarakhand, India",
                "url": "https://ClinicalTrials.gov/show/NCT05484856",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 213, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2016-05-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    79,
                    28
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion",
                "aff": "Anupam Hospital, Rudrapur, Uttrakhand, India",
                "url": "https://ClinicalTrials.gov/show/NCT04340284",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 235, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-10-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    78,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022",
                "aff": "Ibn Sina, Baghdad, Iraq",
                "url": "https://ClinicalTrials.gov/show/NCT05193877",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 210, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2022-02-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    44,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Subtalar Arthrodesis Using AlloStem\u00ae Versus Autologous Bone Graft",
                "aff": "Institute for Foot and Ankle Reconstruction at Mercy, Baltimore, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01413061",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 247, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2010-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Subtalar Arthrodesis Using AlloStem\u00ae Versus Autologous Bone Graft",
                "aff": "Orthopaedic Associates of Michigan, Grand Rapids, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01413061",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 247, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2010-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Subtalar Arthrodesis Using AlloStem\u00ae Versus Autologous Bone Graft",
                "aff": "Minnesota Orthopedic Sports Medicine Institute (MOSMI), Edina, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01413061",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 247, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2010-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Subtalar Arthrodesis Using AlloStem\u00ae Versus Autologous Bone Graft",
                "aff": "Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01413061",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 247, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2010-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of Subtalar Arthrodesis Using AlloStem\u00ae Versus Autologous Bone Graft",
                "aff": "Campbell Clinic, Germantown, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01413061",
                "enrolled": 140,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 247, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2010-06-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)",
                "aff": "Belfast Health and Social Care Trust, Royal Hospitals, Belfast, Northern Ireland, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03042143",
                "enrolled": 129,
                "radius": 21,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 200, 210)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9979,
                "paneLabel": "pane9979",
                "start": "2019-01-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -5,
                    54
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Gingival Crevicular Fluid Bone Morphogenetic Protein - 2 Release Profile Following the Use of Perforated Membrane",
                "aff": "Al azhar universty, Cairo Governorate, Egypt",
                "url": "https://ClinicalTrials.gov/show/NCT01860495",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 214, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-05-22",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    31,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease",
                "aff": "National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189432",
                "enrolled": 77,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 235, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189432",
                "enrolled": 77,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 235, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease",
                "aff": "Seoul National University Seoul, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189432",
                "enrolled": 77,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 235, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease",
                "aff": "Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189432",
                "enrolled": 77,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 235, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189432",
                "enrolled": 77,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 235, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189432",
                "enrolled": 77,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 235, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease",
                "aff": "The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189432",
                "enrolled": 77,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 235, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2016-08-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis",
                "aff": "Soonchunhyang University Hosptial Bucheon, Bucheon, Gyenggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189419",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 215, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-11-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04189419",
                "enrolled": 36,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 215, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-11-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04179760",
                "enrolled": 92,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 221, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2020-03-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs",
                "aff": "University of Minnesota Masonic Cancer Center and Medical Center, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02582775",
                "enrolled": 84,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 227, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2016-09-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids",
                "aff": "West Coast Clinical Trials (WCCT), Cypress, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03197623",
                "enrolled": 58,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 209, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-09-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids",
                "aff": "Diablo Clinical Research, Walnut Creek, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03197623",
                "enrolled": 58,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 209, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-09-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids",
                "aff": "Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03197623",
                "enrolled": 58,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 209, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-09-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids",
                "aff": "Metroplex Clinical Research Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03197623",
                "enrolled": 58,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(230, 209, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-09-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Menstrual Blood Stem Cells in Severe Covid-19",
                "aff": "Avicenna Research Institute, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT05019287",
                "enrolled": 29,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(211, 219, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-04-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Alabama Birmingham (UAB) Hospital, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "UCLA Medical Center, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of California Medical Center, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rocky Mountain Cancer Center, Denver, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northside Hospital, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Northwestern Center for Clinical Research, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Rush University Medical Center, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Chicago Hospitals, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Loyola University Medical Center, Maywood, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Indiana University Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Francis Cancer Center, Indianapolis, Indiana, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Louisville, Louisville, Kentucky, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -85,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Tufts New England Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Dana Farber Cancer Institute, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mayo Medical Center, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Kansas City Cancer Center, Lee's Summit, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -94,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Washington University School of Medicine, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Roswell Park Cancer Institute, Buffalo, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Mount Sinai School of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "New York Presbyterian Hospital, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of North Carolina Hospitals, Chapel Hill, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Duke University Health System, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Jewish Hospital, Cincinnati, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ohio State University, Columbus, Ohio, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -76,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Abramson Cancer Center, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Thomas Jefferson University, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Oncology Hematology Association, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "University of Pittsburgh Cancer Centers, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical University of South Carolina(MUSC), Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Baylor University Medical Center, Dallas, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -96,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "MD Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Fred Hutchinson Cancer Research Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Adelaide Hospital, Adelaide, South Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    138,
                    -34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Melbourne Hospital, Parkville, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    144,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "St. Vincent's Hospital, Darlinghurst, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    151,
                    -33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Royal Brisbane Hospital, Herston, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Peter Lougheed Centre, Calgary, Alberta, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -113,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy and Safety of Prochymal\u00ae Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)",
                "aff": "Princess Margaret Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT00562497",
                "enrolled": 192,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 214, 231)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2008-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03325322",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 248, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2018-01-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Stromal Cell Therapy in Heart Failure",
                "aff": "The Heart Centre, Rigshospitalet University Hospital Copenhagen,, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT00644410",
                "enrolled": 59,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(236, 244, 202)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2008-03-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue Injection",
                "aff": "Hospital Plato, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT04750499",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 219, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-08-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy",
                "aff": "Lehigh Valley Hospital, Allentown, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03015623",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 213, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2017-06-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells Predicting Orthopedic Outcomes",
                "aff": "Dept of Orthopaedic Surgery at University of Nebraska Medical Center, Omaha, Nebraska, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01366911",
                "enrolled": 203,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 239, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2011-06-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cells Predicting Orthopedic Outcomes",
                "aff": "Dept. of Orthopaedic Surgery, Omaha, Nebraska, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01366911",
                "enrolled": 203,
                "radius": 24,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(212, 239, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9976,
                "paneLabel": "pane9976",
                "start": "2011-06-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Assessment of the Efficacy of Stromal Vascular Fraction Treatment for Knee Osteoarthritis",
                "aff": "CelularClinic, Escaldes-Engordany, Andorra",
                "url": "https://ClinicalTrials.gov/show/NCT04749758",
                "enrolled": 66,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 237, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2018-08-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Adipose-derived Regenerative Cells Injection for Treatment of Radiation-induced Rectovaginal Fistula",
                "aff": "South Ural State Medical University, Chelyabinsk, Chelyabinsk Oblast, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT03643614",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 206, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-01-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    61,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Inha University Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Gachon University Gil Hospital, Incheon, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Kangbuk Samsung Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Hanyang University Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Seoul Veterans Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Samsung Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Gangnam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Asan Medical Center, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Korea University Guro Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Follow-Up Study of CARTISTEM\u00ae Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect",
                "aff": "Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT01626677",
                "enrolled": 103,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2012-06-25",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients",
                "aff": "Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT03060551",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 245, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot",
                "aff": "University of Modena and Reggio Emilia, Modena, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03276312",
                "enrolled": 112,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(247, 227, 236)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2015-08-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)",
                "aff": "University of Miami Miller School of Medicine, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00768066",
                "enrolled": 65,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 230, 240)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2008-09-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Concomitant Use of Buccal Fat Pad Derived Cells and Autogenous Bone in Alveolar Cleft Osteoplasty",
                "aff": "School of Dentristry at Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02859025",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 245, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-01-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    51,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Haploidentical Stem Cell Transplantation in Neuroblastoma",
                "aff": "Lund University Hospital, Department of Pediatric Oncology and Bone Marrow Transplantation, Lund, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT00790413",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 239, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2005-10-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.",
                "aff": "UNM Hospital, Albuquerque, New Mexico, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03379168",
                "enrolled": 75,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 236, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2018-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -106,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Freeze-dried Bovine Hydroxyapatite/Secretome Composite for Bone Defects",
                "aff": "Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia",
                "url": "https://ClinicalTrials.gov/show/NCT04980261",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 224, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2020-07-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    112,
                    -7
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products",
                "aff": "National Institutes of Health Clinical Center, Bethesda, Maryland, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01071577",
                "enrolled": 65,
                "radius": 18,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9982,
                "paneLabel": "pane9982",
                "start": "2010-03-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy",
                "aff": "Reina Sof\u00eda University Hospital, C\u00f3rdoba, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT00629096",
                "enrolled": 27,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 225, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2008-03-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery",
                "aff": "Osaka University Hospital, Suita, Osaka, Japan",
                "url": "https://ClinicalTrials.gov/show/NCT04695522",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 245, 246)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2019-10-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    135,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)",
                "aff": "University of Minnesota, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04466098",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 200, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-07-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)",
                "aff": "University of Pittsburgh, Pittsburgh, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04466098",
                "enrolled": 9,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 200, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-07-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)",
                "aff": "Yonsei University College of Medicine, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04495582",
                "enrolled": 8,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(239, 240, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2020-01-03",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Plasmonic Nanophotothermal Therapy of Atherosclerosis",
                "aff": "De Haar Research Task Force, Amsterdam, North Holland, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01270139",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 232, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2007-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Plasmonic Nanophotothermal Therapy of Atherosclerosis",
                "aff": "Ural Center of Modern Nanotechnologies, Institute of Natural Sciences, Ural Federal University, Yekaterinburg, Sverdlovsk Oblast, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT01270139",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 232, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2007-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    60,
                    56
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Plasmonic Nanophotothermal Therapy of Atherosclerosis",
                "aff": "Transfiguration Clinic, Yekaterinburg, Sverdlovsk Oblast, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT01270139",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 232, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2007-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    60,
                    56
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Plasmonic Nanophotothermal Therapy of Atherosclerosis",
                "aff": "Ural Institute of Cardiology, Yekaterinburg, Sverdlovsk Oblast, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT01270139",
                "enrolled": 180,
                "radius": 23,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 232, 213)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9977,
                "paneLabel": "pane9977",
                "start": "2007-04-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    60,
                    56
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow",
                "aff": "University of Li\u00e8ge, Li\u00e8ge, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT01544712",
                "enrolled": 50,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 212, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2004-03-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis",
                "aff": "KyungHee University Gangdong Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02658344",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 226, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-01-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis",
                "aff": "GangNam Severance Hospital, Seoul, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT02658344",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 226, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2015-01-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)",
                "aff": "Mayo Clinic, Scottsdale, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04847739",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 210, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)",
                "aff": "Office of Phillip Fleshner, MD, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04847739",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 210, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)",
                "aff": "Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04847739",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 210, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04847739",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 210, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)",
                "aff": "Vanderbuilt University Medical Center Diagnostic Laboratory, Nashville, Tennessee, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04847739",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 210, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2021-08-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia",
                "aff": "University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04007081",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 219, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2019-09-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Ophthalmology Treatment Study II",
                "aff": "MD Stem Cells, Westport, Connecticut, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03011541",
                "enrolled": 500,
                "radius": 32,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 217, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9968,
                "paneLabel": "pane9968",
                "start": "2016-01-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Ophthalmology Treatment Study II",
                "aff": "MD Stem Cells, Coral Springs, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03011541",
                "enrolled": 500,
                "radius": 32,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 217, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9968,
                "paneLabel": "pane9968",
                "start": "2016-01-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    26
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Ophthalmology Treatment Study II",
                "aff": "Medcare Orthopaedics & Spine Hospital, Dubai, United Arab Emirates",
                "url": "https://ClinicalTrials.gov/show/NCT03011541",
                "enrolled": 500,
                "radius": 32,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 217, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9968,
                "paneLabel": "pane9968",
                "start": "2016-01-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    55,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts",
                "aff": "Hospital Municipal Carmino Caricchio, Sao Paulo, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01771913",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(225, 217, 209)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2012-01-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -46,
                    -23
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy",
                "aff": "University of New Mexico School of Medicine, Albuquerque, New Mexico, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04445220",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 232, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -106,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04445220",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 232, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-10-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells for Degenerative Meniscus Injury",
                "aff": "ICATME-Hospital Quiron Dexeus, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02033525",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 208, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-01-31",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.",
                "aff": "University Medical Center Utrecht, Utrecht, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT02037204",
                "enrolled": 35,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 240, 214)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-01-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
                "aff": "Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04137562",
                "enrolled": 118,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
                "aff": "Korea University AnSan Hospital, Ansan, Gyeonggi-do, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04137562",
                "enrolled": 118,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    127,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
                "aff": "Chung-Ang University Hospital, Seoul, Seoulteukbyeolsi, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04137562",
                "enrolled": 118,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
                "aff": "Kyunghee University Medical Center, Seoul, Seoulteukbyeolsi, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04137562",
                "enrolled": 118,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
                "aff": "Seoul National University Hospital, Seoul, Seoulteukbyeolsi, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04137562",
                "enrolled": 118,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis",
                "aff": "SMG-SNU Boramae Medical Center, Seoul, Seoulteukbyeolsi, Korea, Republic of",
                "url": "https://ClinicalTrials.gov/show/NCT04137562",
                "enrolled": 118,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 228, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2019-11-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    49,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Inflammatory Response After Muscle and Skeleton Trauma",
                "aff": "Clinic of Anesthesiology and Clinic of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, Ulm, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT00710411",
                "enrolled": 48,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 213, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2009-07-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Angers, Angers, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Besan\u00e7on Jean Minjoz, Besancon, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Brest Cavale Blanche, Brest, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -4,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Clermont Ferrand Gabriel Montpied, Clermont Ferrand, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Grenoble Michallon Hospital, Grenoble, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Grenoble South Hospital, Grenoble, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    5,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Nancy Central Hospital, Nancy, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    6,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Nantes H\u00f4tel Dieu, Nantes, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -1,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Piti\u00e9 Salp\u00e9tri\u00e8re AH HP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UH Tours CHRU Trousseau, Tours, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    37,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture",
                "aff": "UHTOURS, Tours, France",
                "url": "https://ClinicalTrials.gov/show/NCT00512434",
                "enrolled": 85,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(241, 248, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2007-08-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    37,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells in Living Donor Kidney Transplantation",
                "aff": "Houston Methodist Hospital System, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03478215",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(238, 233, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-03-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia",
                "aff": "Cardiovascular Lab. 2014, The Heart Centre, Rigshospitalet, Blegdamcvej 9, Copenhagen, Denmark",
                "url": "https://ClinicalTrials.gov/show/NCT00260338",
                "enrolled": 31,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 204, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2005-11-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Fistula Plug in Post Surgical Leak Fistulas",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02807389",
                "enrolled": 2,
                "radius": 11,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 238, 199)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9989,
                "paneLabel": "pane9989",
                "start": "2017-03-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia",
                "aff": "CHU de BORDEAUX, Bordeaux, France",
                "url": "https://ClinicalTrials.gov/show/NCT03968198",
                "enrolled": 43,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 227, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia",
                "aff": "CHU de LIMOGES, Limoges, France",
                "url": "https://ClinicalTrials.gov/show/NCT03968198",
                "enrolled": 43,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 227, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia",
                "aff": "Rangueil Hospital, Toulouse, France",
                "url": "https://ClinicalTrials.gov/show/NCT03968198",
                "enrolled": 43,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 227, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-03-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    1,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer",
                "aff": "University College London Hospital, London, United Kingdom",
                "url": "https://ClinicalTrials.gov/show/NCT03298763",
                "enrolled": 46,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 238, 235)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-03-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Coated Fistula Plug in Patients With Crohn's RVF",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03220243",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(215, 237, 200)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-09-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02589119",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(217, 237, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2016-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03608579",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 204, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2018-10-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)",
                "aff": "University of Florida, Gainesville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04723303",
                "enrolled": 22,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(220, 203, 233)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-09-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -82,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Stem Cell Study for Adult TBI (Phase 2b)",
                "aff": "The University of Texas Health Science Center at Houston, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02525432",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 249, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2016-10-21",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Arizona Pain Specialists, Scottsdale, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "UC Davis Spine Center, Sacramento, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -121,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "The Spine Institute, Santa Monica, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "IPM Medical Group, Inc., Walnut Creek, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Denver Spine, Denver, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Rocky Mountain Associates in Orthopedic Medicine, P.C., Loveland, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -105,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Emory University School of Medicine, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Carolina Neurosurgery and Spine Associates, Charlotte, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Central Texas Spine Institute, Austin, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -97,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Richmond Bone and Joint Clinic, Memorial Hermann Medical Group, Richmond, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Virginia Spine Research Institute, Inc., Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Washington Center for Pain Management, Edmonds, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "The Center for Pain Relief, Inc., Charleston, West Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain",
                "aff": "Monash Medical Center, Clayton, Victoria, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01290367",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 222, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2011-02-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    145,
                    -37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Ospedali Riuniti Umberto I, Ancona, AN, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "IRCCS AOU San martino IST, Genova, GE, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Ospedale Civile degli Infermi, Rimini, RN, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Azienda Ospedaliera Cannizzaro, Catania, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    15,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Ospedale Maggiore della Carit\u00e0, Novara, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    8,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Istituto Oncologico del Veneto (IOV) - Universit\u00e0 di Padova, Padova, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Policlinico Universitario Campus Bio-Medico, Roma, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    12,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.",
                "aff": "Ospedale Sacro Cuore Don Calabria (Negrar), Verona, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03381326",
                "enrolled": 94,
                "radius": 19,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(222, 223, 225)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9981,
                "paneLabel": "pane9981",
                "start": "2014-11-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)",
                "aff": "Mayo Clinic, Scottsdale, Arizona, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03268603",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2017-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -111,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)",
                "aff": "Mayo Clinic, Jacksonville, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03268603",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2017-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -81,
                    30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03268603",
                "enrolled": 60,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(235, 215, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2017-09-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease",
                "aff": "Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01090817",
                "enrolled": 21,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(223, 243, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2010-03-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells in Kidney Transplant Recipients",
                "aff": "U.O. Nefrologia e Dialisi, Bergamo, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02012153",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 204, 234)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2013-11-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",
                "aff": "H\u00e9matologie et th\u00e9rapie cellulaire, H\u00f4pital Saint Antoine, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT02814864",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 222, 215)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-04-14",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection",
                "aff": "CHU de Li\u00e8ge, Li\u00e8ge, Belgium",
                "url": "https://ClinicalTrials.gov/show/NCT04445454",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 227, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2020-06-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -2,
                    53
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta",
                "aff": "The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01061099",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 224, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2010-02-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.",
                "aff": "Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01659762",
                "enrolled": 16,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(213, 241, 244)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2012-07-08",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation",
                "aff": "M D Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03608631",
                "enrolled": 28,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(209, 228, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2021-01-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC Therapy in Liver Transplantation",
                "aff": "U.S.C Nefrologia e Dialisi, Bergamo, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02260375",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 249, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-09-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC Therapy in Liver Transplantation",
                "aff": "USC Chirurgia Generale III, Bergamo, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02260375",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 249, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-09-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC Therapy in Liver Transplantation",
                "aff": "USC Ematologia, Bergamo, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02260375",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 249, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-09-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC Therapy in Liver Transplantation",
                "aff": "USC Gastroenterologia, Bergamo, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02260375",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 249, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-09-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    9,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC Therapy in Liver Transplantation",
                "aff": "Servizio di Immunoematologia e Medicina Trasfusionale, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02260375",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 249, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-09-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC Therapy in Liver Transplantation",
                "aff": "Unit\u00e0 Chirurgia Generale e Trapianti, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT02260375",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(245, 249, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2014-09-09",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02805855",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 249, 205)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2016-09-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma",
                "aff": "Children's Healthcare of Atlanta, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT05035862",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 239, 224)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-03-16",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs",
                "aff": "Children's Hospital of Alabama, Birmingham, Alabama, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00957931",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 230, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2009-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -86,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs",
                "aff": "University of Minnesota, Minneapolis, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT00957931",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(233, 230, 204)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2009-03-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -93,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema",
                "aff": "Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands",
                "url": "https://ClinicalTrials.gov/show/NCT01306513",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 200, 242)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-03-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    52
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome",
                "aff": "The Ottawa Hospital, Ottawa, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT04400032",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(227, 243, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-05-15",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "BMT Autologous MSCs for GvHD",
                "aff": "Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02359929",
                "enrolled": 11,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 200, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-02-10",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -84,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hCT-MSC in Children With Autism Spectrum Disorder",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04089579",
                "enrolled": 164,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 236, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2020-09-12",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation",
                "aff": "TPCH, Brisbane, Queensland, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01175655",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 227, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-02-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    153,
                    -27
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation",
                "aff": "RPH, Perth, Western Australia, Australia",
                "url": "https://ClinicalTrials.gov/show/NCT01175655",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(216, 227, 216)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2010-02-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    115,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema",
                "aff": "Pontificia Universidade Catolica do Parana, Curitiba, PR, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01872624",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 247, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-06-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -49,
                    -25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema",
                "aff": "Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01872624",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 247, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-06-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -43,
                    -22
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema",
                "aff": "Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, RS, Brazil",
                "url": "https://ClinicalTrials.gov/show/NCT01872624",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 247, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2013-06-07",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -51,
                    -30
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells (MSC\u00b4s) in Renal Lupus",
                "aff": "Cl\u00ednica Universidad de los Andes, Santiago de Chile, Regi\u00f3n Metropolitana, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT03917797",
                "enrolled": 39,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 231, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-04-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells (MSC\u00b4s) in Renal Lupus",
                "aff": "Hospital Barros Luco Trudeau, Santiago de Chile, Regi\u00f3n Metropolitana, Chile",
                "url": "https://ClinicalTrials.gov/show/NCT03917797",
                "enrolled": 39,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(250, 231, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-04-02",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    -31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas",
                "aff": "Mayo Clinic in Minnesota, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03209700",
                "enrolled": 7,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 200, 239)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2017-07-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Pediatric MSC-AFP Sub-study for Crohn's Fistula",
                "aff": "Mayo Clinic in Rochester, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03449069",
                "enrolled": 5,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 225, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2018-07-23",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Mesenchymal Stromal Cells and Osteoarthritis",
                "aff": "University Hospital Dresden, Orthopaedic Department, Dresden, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01038596",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(246, 225, 248)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2009-11-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    13,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.",
                "aff": "Istituto Ortopedico Rizzoli, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT05465096",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(243, 207, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2022-07-19",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer",
                "aff": "University of Wisconsin, Madison, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04489732",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 236, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-02-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -89,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants",
                "aff": "Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare, Moscow, Russian Federation",
                "url": "https://ClinicalTrials.gov/show/NCT05490173",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 238, 227)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-08-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    37,
                    55
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of California at San Francisco, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Alfred I. DuPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Albert Einstein College of Medicine, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Oregon University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Fred Hutchinson Cancer Research, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02336230",
                "enrolled": 55,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(208, 225, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2015-06-04",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 216, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-04-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS",
                "aff": "H\u00f4pital Europ\u00e9en Georges Pompidou - APHP, Paris, France",
                "url": "https://ClinicalTrials.gov/show/NCT04333368",
                "enrolled": 47,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 216, 243)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2020-04-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors",
                "aff": "CHU de Saint-Etienne, Saint-Priest-en-Jarez, France",
                "url": "https://ClinicalTrials.gov/show/NCT03233074",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 222, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors",
                "aff": "CHU de Saint-Etienne, Saint-\u00c9tienne, France",
                "url": "https://ClinicalTrials.gov/show/NCT03233074",
                "enrolled": 150,
                "radius": 22,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 222, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9978,
                "paneLabel": "pane9978",
                "start": "2017-10-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Tolerance by Engaging Antigen During Cellular Homeostasis",
                "aff": "Duke University Health System, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03504241",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 204, 197)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2018-07-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    35
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA",
                "aff": "Toronto Western Hospital, Toronto, Ontario, Canada",
                "url": "https://ClinicalTrials.gov/show/NCT02351011",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 236, 207)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2015-01-30",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans",
                "aff": "Cell Therapy Center, University of Jordan, Amman, Jordan",
                "url": "https://ClinicalTrials.gov/show/NCT04815213",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(232, 215, 221)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in SCI",
                "aff": "Hospital Puerta de Hierro, Majadahonda, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT02165904",
                "enrolled": 10,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(240, 206, 247)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2014-06-18",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)",
                "aff": "Far Eastern Memorial Hospital, Taipei, Taiwan",
                "url": "https://ClinicalTrials.gov/show/NCT03007576",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(253, 227, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-01-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring",
                "aff": "Karolinska Trial Alliance, Stockholm, Sweden",
                "url": "https://ClinicalTrials.gov/show/NCT04290182",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(231, 217, 203)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2020-02-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    18,
                    59
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease",
                "aff": "M D Anderson Cancer Center, Houston, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04744116",
                "enrolled": 24,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 216, 220)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-02-17",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -95,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis",
                "aff": "UH Montpellier, Montpellier, France",
                "url": "https://ClinicalTrials.gov/show/NCT02838069",
                "enrolled": 100,
                "radius": 20,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(214, 206, 217)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9980,
                "paneLabel": "pane9980",
                "start": "2016-08-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04294290",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(219, 200, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2021-02-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "The Treatment of Initial Stage of Hip Osteonecrosis: the Core Decompression",
                "aff": "Istituto Ortopedico Rizzli, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT04210440",
                "enrolled": 52,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(251, 248, 219)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2003-03-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hCT-MSC Infusion in Adults With Autism Spectrum Disorder",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04484077",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(248, 242, 237)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2022-01-24",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE",
                "aff": "Duke University, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03635450",
                "enrolled": 6,
                "radius": 12,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(226, 201, 245)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9988,
                "paneLabel": "pane9988",
                "start": "2018-11-27",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "hCT-MSCs for Children With Autism Spectrum Disorder (ASD)",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03099239",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(237, 249, 226)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2017-06-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Stem Cell Fistula Plug in Perianal Crohn's Disease",
                "aff": "Mayo Clinic, Rochester, Minnesota, United States",
                "url": "https://ClinicalTrials.gov/show/NCT01915927",
                "enrolled": 20,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(252, 210, 229)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2013-07-05",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -92,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Impact of Semaglutide on CD34+ EPC and Fat Derived MSC",
                "aff": "The GW Medical Faculty Associates, Washington, District of Columbia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT04126603",
                "enrolled": 40,
                "radius": 16,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(224, 209, 211)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9984,
                "paneLabel": "pane9984",
                "start": "2019-09-01",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "ADIPOA - Clinical Study",
                "aff": "UH Montpellier, Montpellier, France",
                "url": "https://ClinicalTrials.gov/show/NCT01585857",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 236, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2012-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    3,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "ADIPOA - Clinical Study",
                "aff": "Orthop\u00e4dische Klinik, W\u00fcrzburg, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01585857",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(228, 236, 228)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2012-04-26",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    51
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear",
                "aff": "MGH, Massachusetts General Hospital, Boston, Massachusetts, United States",
                "url": "https://ClinicalTrials.gov/show/NCT03909139",
                "enrolled": 300,
                "radius": 27,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(254, 207, 222)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9973,
                "paneLabel": "pane9973",
                "start": "2019-08-06",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -71,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury",
                "aff": "Hospital de Neurorehabilitaci\u00f3 Institut Guttmann, Badalona, Barcelona, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05054803",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 238, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-09-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    2,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury",
                "aff": "Complexo Hospitalario Universitario A Coru\u00f1a (CHUAC), A Coru\u00f1a, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT05054803",
                "enrolled": 18,
                "radius": 14,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 238, 212)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9986,
                "paneLabel": "pane9986",
                "start": "2021-09-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -8,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas",
                "aff": "S. Orsola-Malpighi Hospital, Bologna, BO, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT03555773",
                "enrolled": 15,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(207, 249, 230)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2016-05-11",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.",
                "aff": "Hadassah Medical Organization, Jerusalem, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT01051882",
                "enrolled": 12,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(221, 223, 201)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2011-01-20",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)",
                "aff": "Hadassah Medical Organization, Jerusalem, Israel",
                "url": "https://ClinicalTrials.gov/show/NCT01777646",
                "enrolled": 14,
                "radius": 13,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(242, 209, 232)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9987,
                "paneLabel": "pane9987",
                "start": "2012-01-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    35,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Los Angeles, Los Angeles, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -118,
                    34
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "CHOC Children's Hospital of Orange County, Orange, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -117,
                    33
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "UCSF Benioff Children's Hospital, San Francisco, California, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital Colorado Center for Cancer/Blood Disorders, Aurora, Colorado, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -104,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Alfred I. duPont Hospital for Children of the Nemours Foundation, Wilmington, Delaware, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -75,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Miami Children's Research Institute, Miami, Florida, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -80,
                    25
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -87,
                    41
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Children's Hospital of Michigan, Detroit, Michigan, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -83,
                    42
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "University of Mississippi Medical Center, Jackson, Mississippi, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Washington University, Saint Louis, Missouri, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -90,
                    38
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Columbia University Medical Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Memorial Sloan Kettering Cancer Center, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -73,
                    40
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "The Children's Hospital at Montefiore, New York, New York, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -115,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Duke University Medical Center, Durham, North Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -78,
                    36
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Oregon Health & Science University, Portland, Oregon, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    45
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical University of South Carolina, Charleston, South Carolina, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -79,
                    32
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Texas Transplant Institute, San Antonio, Texas, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -98,
                    29
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Virginia Commonwealth University, Richmond, Virginia, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -77,
                    37
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Fred Hutchinson Cancer Center, Seattle, Washington, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -122,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD",
                "aff": "Medical College of Wisconsin, Milwaukee, Wisconsin, United States",
                "url": "https://ClinicalTrials.gov/show/NCT02652130",
                "enrolled": 32,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(249, 241, 223)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2015-09-28",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -88,
                    43
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis",
                "aff": "General Hospital of Chinese Armed Police Force, Beijing, China",
                "url": "https://ClinicalTrials.gov/show/NCT02162693",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 220, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2013-06-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    116,
                    39
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis",
                "aff": "Shanghai Renji Hospital, Shanghai, China",
                "url": "https://ClinicalTrials.gov/show/NCT02162693",
                "enrolled": 53,
                "radius": 17,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(229, 220, 238)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9983,
                "paneLabel": "pane9983",
                "start": "2013-06-13",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    121,
                    31
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing",
                "aff": "Depatment of Orthopaedic Surgery, H\u00f4pital Henri Mondor, Cr\u00e9teil, France",
                "url": "https://ClinicalTrials.gov/show/NCT01842477",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-04-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    4,
                    46
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing",
                "aff": "Department of Orthopaedic Surgery, CHRU Tours, Tours, France",
                "url": "https://ClinicalTrials.gov/show/NCT01842477",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-04-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    0,
                    47
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing",
                "aff": "Department of Orthopaedic Trauma, University of Ulm, Ulm, Germany",
                "url": "https://ClinicalTrials.gov/show/NCT01842477",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-04-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    10,
                    48
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing",
                "aff": "Istituto Ortopedico Rizzoli, Bologna, Bologna, Italy",
                "url": "https://ClinicalTrials.gov/show/NCT01842477",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-04-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    11,
                    44
                ]
            }
        },
        {
            "type": "Feature",
            "properties": {
                "name": "Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing",
                "aff": "Servicio de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda \"A\", Hospital La Paz, Madrid, Spain",
                "url": "https://ClinicalTrials.gov/show/NCT01842477",
                "enrolled": 30,
                "radius": 15,
                "color": "rgb(100, 100, 100)",
                "fillColor": "rgb(255, 220, 198)",
                "opacity": 0.8,
                "fillOpacity": 0.8,
                "zindex": 9985,
                "paneLabel": "pane9985",
                "start": "2013-04-29",
                "end": "2024-09-30"
            },
            "geometry": {
                "type": "Point",
                "coordinates": [
                    -3,
                    40
                ]
            }
        }
    ]
}